0001477932-22-005413.txt : 20220727 0001477932-22-005413.hdr.sgml : 20220727 20220727061451 ACCESSION NUMBER: 0001477932-22-005413 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 45 CONFORMED PERIOD OF REPORT: 20220531 FILED AS OF DATE: 20220727 DATE AS OF CHANGE: 20220727 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trident Brands Inc CENTRAL INDEX KEY: 0001421907 STANDARD INDUSTRIAL CLASSIFICATION: DAIRY PRODUCTS [2020] IRS NUMBER: 261367322 STATE OF INCORPORATION: NV FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53707 FILM NUMBER: 221108752 BUSINESS ADDRESS: STREET 1: 433 PLAZA REAL, SUITE 275 CITY: BOCA RATON STATE: FL ZIP: 33432 BUSINESS PHONE: 262-789-6689 MAIL ADDRESS: STREET 1: 433 PLAZA REAL, SUITE 275 CITY: BOCA RATON STATE: FL ZIP: 33432 FORMER COMPANY: FORMER CONFORMED NAME: Sandfield Ventures Corp. DATE OF NAME CHANGE: 20071220 10-Q 1 tdnt_10q.htm FORM 10-Q tdnt_10q.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q 

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED MAY 31, 2022

 

Commission file number 000-53707

 

TRIDENT BRANDS INCORPORATED

(Exact name of registrant as specified in its charter)

 

Nevada

(State or other jurisdiction of incorporation or organization)

 

433 Plaza Real, Suite 275

Boca Raton, FL 33432

(Address of principal executive offices, including zip code.)

 

(561) 962-4122

(Telephone number, including area code)

 

Resident Agents of Nevada

711 S. Carson Street, Suite 4

Carson City, NV 89701

(Name and Address of Agent for Service)

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days. Yes ☒      NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated Filer

Smaller reporting company

Emerging Growth Company

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES NO ☒

 

The number of the registrant’s common shares outstanding as of July 27, 2022 was 37,311,887.

 

 

 

 

TRIDENT BRANDS INCORORATED

FORM 10-Q

For the quarterly period ended May 31, 2022

 

TABLE OF CONTENTS

 

PART I

FINANCIAL INFORMATION

 

 

 

Item 1.

Financial Statements (Unaudited)

 

6

 

 

Consolidated Balance Sheets as at May 31, 2022 and November 30, 2021

 

6

 

 

Consolidated Statements of Operations for the three and six months ended May 31, 2022 and May 31, 2021

 

7

 

 

Consolidated Statements of Changes in Stockholders’ Deficit for the six months ended May 31, 2022 and May 31, 2021

 

8

 

 

Consolidated Statements of Cash Flows for the six months ended May 31, 2022 and May 31, 2021

 

9

 

 

Notes to Consolidated Financial Statements

 

10

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

17

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

22

 

Item 4.

Controls and Procedures

 

22

 

 

 

PART II

OTHER INFORMATION

 

23

 

Item 6.

Exhibits

 

25

 

 

 
2

Table of Contents

 

Basis of Presentation

 

Except where the context otherwise requires, all references in this Quarterly Report on Form 10-Q (“Form 10-Q”) to the “Company”, “we”, “us”, “our”, “Trident” and “Trident Brands” or similar words and phrases are to Trident Brands Incorporated and its subsidiaries, taken together.

 

In this report, all currency amounts are expressed in thousands of United States (“U.S.”) dollars (“$”), except per share data, unless otherwise stated. Amounts expressed in other than U.S. dollars are noted accordingly. For example, amounts if expressed in Canadian dollars are expressed in thousands of Canadian dollars and preceded by the symbol “Cdn $”.

 

Forward-Looking Statements

 

This Form 10-Q contains forward-looking statements which are based on our current expectations and assumptions and involve a number of risks and uncertainties. Generally, forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as “anticipate”, “estimate”, “intend”, “project”, “potential”, “continue”, “believe”, “expect”, “could”, “would”, “should”, “might”, “plan”, “will”, “may”, “predict”, the negatives of such terms, and words and phrases of similar impact and include, but are not limited to references to expected increases in revenues and margins, growth opportunities, the success of new product launches and line extensions, our ability to finance our business, potential strategic investments, business strategies, competitive strengths, goals, references to key markets where we operate and the market for our securities. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on certain assumptions and analyses we make in light of our experience and our interpretation of current conditions, historical trends and expected future developments, as well as other factors that we believe are appropriate in the circumstance.

 

Whether actual results and developments will agree with our expectations and predictions is subject to many risks and uncertainties. Accordingly, there are or will be important factors that could cause our actual results to differ materially from our expectations and predictions. We believe these factors include, but are not limited to, the following:

 

 

we have a limited operating history with significant losses and expect losses to continue for the foreseeable future;

 

 

 

 

we have an urgent need for additional capital to fund our business operations and if we ae unable to secure needed capital, there will be a material adverse effect on our business and financial condition;

 

 

 

 

we could face intense competition, which could result in lower revenues and higher expenditures and could adversely affect our results of operations;

 

 

 

 

we are governed by only four persons serving as directors and officers which may lead to faulty corporate governance;

 

 

 

 

we must attract and maintain key personnel or our business may fail;

 

 

 

 

we may not be able to secure additional financing to meet our future capital needs due to changes in general economic conditions;

 

 

 

 

our business and operating results could be harmed if we fail to manage our growth or change;

 

 

 

 

we have a limited operating history and if we are not successful in growing our business, then we may have to scale back or even cease our ongoing business operations;

 

 

 

 

if our intellectual property is not adequately protected, then we may not be able to compete effectively and we may not be profitable;

 

 

 

 

if we are the subject of an intellectual property infringement claim, the cost of participating in any litigation could impact our ability to stay in business;

 

 

 

 

we could lose our competitive advantages if we are not able to protect any of our food and nutritional products and intellectual property rights against infringement, and any related litigation could be time-consuming and costly;

 

 
3

Table of Contents

 

 

if we fail to effectively manage our growth our future business results could be harmed and our managerial and operational resources may be strained;

 

 

 

 

our services may become obsolete and unmarketable if we are unable to respond adequately to rapidly changing technology and customer demands;

 

 

 

 

our failure to appropriately respond to changing consumer preferences and demand for new products or product enhancements could significantly harm product sales and harm our financial condition and operating results;

 

 

 

 

if we do not introduce new products or make enhancements to adequately meet the changing needs of our customers, some of our products could fail in the marketplace, which could negatively impact our revenues, financial condition and operating results;

 

 

 

 

we are affected by laws and governmental regulations with potential penalties or claims, which could harm our financial condition and operating results;

 

 

 

 

since we rely on independent third parties for the manufacture and supply of our products, if these third parties fail to reliably supply products to us at required levels of quality and which are manufactured in compliance with applicable laws, then our financial condition and operating results would be harmed;

 

 

 

 

we may incur material product liability claims, which could increase our costs and harm our financial condition and operating results;

 

 

 

 

unless we can generate sufficient cash from operations or raise additional funds, we may not be able to meet our debt and other obligations;

 

 

 

 

our customers generally are not obligated to continue purchasing products from us;

 

 

 

 

if we do not manage our supply chain effectively, our operating results may be adversely affected;

 

 

 

 

our stock price may be volatile, which may result in losses to our shareholders;

 

 

 

 

our common shares are thinly traded and our shareholders may be unable to sell at or near ask prices, or at all;

 

 

 

 

the market price for our common stock is particularly volatile given our status as a relatively small and developing company, which could lead to wide fluctuations in our share price. Our shareholders may be unable to sell your common stock at or above their purchase price if at all, which may result in substantial losses;

 

 

 

 

we do not anticipate paying any cash dividends to our common shareholders and as a result shareholders may only realize a return when the shares are sold;

 

 

 

 

we are quoted on the OTCQB quotation system and our common stock is subject to “penny stock” rules which could negatively impact our liquidity and our shareholders’ ability to sell their shares;

 

 

 

 

volatility in our common share price may subject us to securities litigation;

 

 

 

 

the elimination of monetary liability against our directors, officers and employees under Nevada law and the existence of indemnification rights of our directors, officers and employees may result in substantial expenditures by our company and may discourage lawsuits against our directors, officers and employees;

 

 

 

 

our business is subject to changing regulations related to corporate governance and public disclosure that have increased both our costs and the risk of noncompliance; and

 

 

 

 

The ongoing coronavirus outbreak could have an adverse effect on our business.

 

 

 

 

 

Concerns remain about the global outbreak of a novel strain of coronavirus (COVID-19). The virus spread rapidly across the globe, including the U.S. The pandemic had an unprecedented impact on the U.S. economy as federal, state and local governments reacted to this public health crisis, which has created significant uncertainties. These uncertainties include, but are not limited to, the potential adverse effect of the pandemic on the economy, our customers and supply chain.

 

 

 

 

 

Consumer fear about becoming ill with the virus and recommendations and/or mandates from federal, state and local authorities to avoid large gatherings of people or self-quarantine may continue. The extent of the impact of the pandemic on our business and financial results will depend largely on future developments, including the duration of the outbreak within the U.S., the impact on capital and financial markets and the related impact on consumer confidence and spending, all of which are highly uncertain and cannot be predicted. This situation is changing rapidly, and additional impacts may arise that we are not aware of currently.

 

 
4

Table of Contents

 

Consequently all forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that our actual results or the developments we anticipate will be realized. The foregoing factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this report.

 

Corporate Legal Structure and Related Matters

 

Trident Brands Incorporated has two legal subsidiaries, as detailed below.

 

tdnt_10qimg1.jpg

 

Brain Armor Inc. is 70.5% owned by Trident Brands and is organized to develop, market and sell a portfolio of DHA supplements under the Brain Armor® brand targeted at the cognitive health and performance segment.

 

Trident Brands Canada Ltd. is 100% owned by Trident Brands Incorporated and holds various banking facilities, and licenses associated with the manufacturing, importation and sale of natural health and nutrition products in Canada.

 

The Company’s administrative office is located at 433 Plaza Real, Suite 275, Boca Raton, FL 33432 and its fiscal year end is November 30th.

 

The Company has authorized capital of 300,000,000 common shares with a par value of $0.001 per share. 33,311,887 common shares were issued and outstanding as of May 31, 2022 and 33,311,887 as of July 27, 2022.

 

 
5

Table of Contents

 

ITEM 1. FINANCIAL STATEMENTS

 

The unaudited financial statements for the quarter ended May 31, 2022 immediately follow.

 

TRIDENT BRANDS INCORPORATED

Consolidated Balance Sheets

(Unaudited)

 

 

 

As of

 

 

As of

 

 

 

May 31,

 

 

November 30,

 

 

 

2022

 

 

2021

 

 

 

(unaudited)

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash

 

$12,389

 

 

$7,653

 

Accounts Receivable, net of allowance for doubtful accounts of $11,286 and $160,210, respectively

 

 

1,073

 

 

 

12,358

 

Inventory, net of reserves of $401,606 and $401,606, respectively

 

 

735,476

 

 

 

881,924

 

Prepaid and other current assets

 

 

419

 

 

 

158,146

 

 

 

 

 

 

 

 

 

 

Total Current Assets

 

 

749,357

 

 

 

1,060,081

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$749,357

 

 

$1,060,081

 

 

 

 

 

 

 

 

 

 

LIABILITIES & STOCKHOLDERS' DEFICIT

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts Payable

 

$549,941

 

 

$524,207

 

Accrued Liabilities

 

 

10,485,801

 

 

 

9,405,833

 

 

 

 

 

 

 

 

 

 

Total Current Liabilities

 

 

11,035,742

 

 

 

9,930,040

 

 

 

 

 

 

 

 

 

 

Convertible Debt, net of discount of $0 and $0, respectively

 

 

22,300,000

 

 

 

22,300,000

 

 

 

 

 

 

 

 

 

 

Total Liabilities

 

 

33,335,742

 

 

 

32,230,040

 

 

 

 

 

 

 

 

 

 

Stockholders' Deficit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common stock, $0.001 par value, 300,000,000 shares authorized; 37,311,887 and 33,311,887 shares issued and outstanding as of May 31, 2022 and November 30, 2021 respectively

 

 

37,312

 

 

 

32,312

 

Additional paid-in capital

 

 

11,608,630

 

 

 

11,492,630

 

Non-Controlling Interest in Subsidiary

 

 

(633,495 )

 

 

(490,852 )

Accumulated Deficit

 

 

(43,598,832 )

 

 

(42,205,049 )

 

 

 

 

 

 

 

 

 

Total Stockholders' Deficit

 

 

(32,586,385 )

 

 

(31,169,959 )

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT

 

$749,357

 

 

$1,060,081

 

 

See Notes to Unaudited Consolidated Financial Statements

 

 
6

Table of Contents

 

TRIDENT BRANDS INCORPORATED

Consolidated Statements of Operations

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months

 

 

Three Months

 

 

Six Months

 

 

Six Months

 

 

 

Ended

 

 

Ended

 

 

Ended

 

 

Ended

 

 

 

May 31,

 

 

May 31,

 

 

May 31,

 

 

May 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenues, net

 

$125,280

 

 

$46,243

 

 

$125,280

 

 

$190,291

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of Sales

 

 

146,448

 

 

 

24,580

 

 

 

146,448

 

 

 

103,368

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Profit

 

 

(21,168)

 

 

21,663

 

 

 

(21,168)

 

 

86,923

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General & Administrative Expenses

 

 

(528,103)

 

 

(537,978)

 

 

(945,412)

 

 

(942,262)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from Operations

 

 

(549,271)

 

 

(516,315)

 

 

(966,580)

 

 

(855,339)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Income (Expenses)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest Expense, net

 

 

(234,171)

 

 

(200,008)

 

 

(569,846)

 

 

(400,341)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Other Income (Expenses)

 

 

(234,171)

 

 

(200,008)

 

 

(569,846)

 

 

(400,341)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss

 

$(783,442)

 

$(716,323)

 

$(1,536,426)

 

$(1,255,680)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to Trident

 

 

(703,825)

 

 

(646,092)

 

 

(1,393,783)

 

 

(1,181,590)

Net loss attributable to Non-Controlling Interests

 

 

(79,617)

 

 

(70,231)

 

 

(142,643)

 

 

(74,090)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss per share - Basic and diluted

 

$(0.02)

 

$(0.02)

 

$(0.04)

 

$(0.04)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding - Basic and diluted

 

 

37,181,452

 

 

 

32,311,887

 

 

 

35,267,931

 

 

 

32,311,887

 

 

See Notes to Unaudited Consolidated Financial Statements

 

 
7

Table of Contents

 

TRIDENT BRANDS INCORPORATED

Consolidated Statements of Changes in Stockholders’ Deficit

For the six months ended May 31, 2022 and May 31, 2021

(Unaudited)

 

 

 

 

 

 

Common

 

 

Additional

 

 

 

 

 

Non-

 

 

 

 

 

 

Common 

 

 

Stock

 

 

Paid-in

 

 

Accumulated

 

 

Controlling

 

 

 

 

 

 

Stock

 

 

Amount

 

 

Capital

 

 

 Deficit

 

 

 Interest

 

 

 Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, November 30, 2020

 

 

32,311,887

 

 

$32,312

 

 

$11,458,630

 

 

$(39,522,278 )

 

$(387,147 )

 

$(28,418,483 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss,  February 28, 2021

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(535,498 )

 

 

(3,859 )

 

 

(539,357 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, February 28, 2021

 

 

32,311,887

 

 

$32,312

 

 

$11,458,630

 

 

$(40,057,776 )

 

$(391,006 )

 

$(28,957,840 )

NCI Investment in Brain Armor

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

300,000

 

 

 

300,000

 

Net loss,  May 31, 2021

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(646,091 )

 

 

(70,231 )

 

 

(716,323 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, May 31, 2021

 

 

32,311,887

 

 

$32,312

 

 

$11,458,630

 

 

$(40,703,867 )

 

$(161,237 )

 

$(29,374,162 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, November 30, 2021

 

 

33,311,887

 

 

$33,312

 

 

$11,492,630

 

 

$(42,205,049 )

 

$(490,852 )

 

$(31,169,959 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss,  February 28, 2022

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(689,958 )

 

 

(63,026 )

 

 

(752,984 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, February 28, 2022

 

 

33,311,887

 

 

$33,312

 

 

$11,492,630

 

 

$(42,895,007 )

 

$(553,878 )

 

$(31,922,943 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Issuance of Common Shares for services

 

 

 4,000,000

 

 

 $

 4,000

 

 

 $

 116,000

 

 

 

 

 

 

 

 

 

 

 $

 120,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss,  May 31, 2022

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(703,825 )

 

 

(79,617 )

 

 

(783,441 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, May 31, 2022

 

 

37,311,887

 

 

$37,312

 

 

$11,608,630

 

 

$(43,598,832 )

 

$(633,495 )

 

$(32,586,385 )

 

See Notes to Unaudited Consolidated Financial Statements

 

 
8

Table of Contents

 

TRIDENT BRANDS INCORPORATED

Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

Six Months

 

 

Six Months

 

 

 

Ended

 

 

Ended

 

 

 

May 31,

 

 

May 31,

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$(1,536,426 )

 

$(1,255,680 )

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

          Issuance of Common Shares for services

 

 

 120,000

 

 

 

 -

 

Provision for bad debts

 

 

-

 

 

 

2,340

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

11,285

 

 

 

(10,061 )

Prepaid expenses

 

 

157,727

 

 

 

86,272

 

Inventory

 

 

146,448

 

 

 

111,980

 

Accounts payable and accrued liabilities

 

 

1,105,702

 

 

 

808,503

 

 

 

 

 

 

 

 

 

 

Cash provided by (used in) operating activities

 

 

4,736

 

 

 

(256,646 )

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from NCI Investment in Brain Armor

 

 

-

 

 

 

300,000

 

 

 

 

 

 

 

 

 

 

Cash provided by financing activities

 

 

-

 

 

 

300,000

 

 

 

 

 

 

 

 

 

 

NET CHANGE IN CASH AND CASH EQUIVALENTS

 

 

4,736

 

 

 

43,354

 

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

 

 

7,653

 

 

 

88,007

 

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT END OF PERIOD

 

$12,389

 

 

$131,361

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for:

 

 

 

 

 

 

 

 

Income taxes

 

 

-

 

 

 

-

 

Interest

 

 

-

 

 

 

-

 

 

See Notes to Unaudited Consolidated Financial Statements

 

 
9

Table of Contents

 

TRIDENT BRANDS INCORPORATED

Notes to Consolidated Financial Statements

May 31, 2022

(Unaudited)

 

NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Trident Brands Incorporated “we”, “our”, “the Company”) was incorporated under the laws of the State of Nevada on November 5, 2007.

 

The Company is focused on the development of high growth branded and private label consumer products and ingredients within the nutritional supplement, life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super 8-K filing at the end of August, 2014. Activities to date have focused on capital formation, organizational development and execution of its branded and private label consumer products and ingredients business plan.

 

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Form 10-K filed with SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2021 as reported in the Form 10-K have been omitted.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates. The ultimate impact from COVID-19 on the Company’s operations and financial results during 2022 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, the rate at which historically large increases in unemployment rates will decrease, if at all, and whether, and the speed with which the economy recovers. We are not able to fully quantify the impact that these factors will have on our financial results during the remainder of 2022 and beyond, but expect developments related to COVID-19 to continue to materially affect the Company’s financial performance during 2022.

 

Customer Concentration

 

One customer accounted for 100.0% of total revenue for the six month period ended May 31, 2022 compared to two customers who accounted for 19.9% and 11.5% of total revenue for the six month period ended May 31, 2021. Two customers accounted for 66.5% and 33.5% of total accounts receivable as of May 31, 2022 compared to two customers for 39.4% and 29.2% as of May 31, 2021.

 

 
10

Table of Contents

 

Fair Value of Financial Instruments

 

The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

 

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures.

 

Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

 

The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable and note payable. The fair value of the Company’s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of May 31, 2022 the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s consolidated balance sheets on a recurring basis.

 

Recent Accounting Pronouncements

 

The Company has evaluated recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that there are none that will have a material impact on the Company’s financial statements.

 

NOTE 3. GOING CONCERN

 

The accompanying interim consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.

 

As of May 31, 2022, the Company had $12,389 in cash and a working capital deficit of $10,286,385. The Company also has generated losses and has an accumulated deficit as of May 31, 2022. These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless Management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the next 12 months. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

 
11

Table of Contents

 

NOTE 4. WARRANTS AND OPTIONS

 

The following table represents stock option activity for the six month period ended May 31, 2022:

 

 

 

Number of

Options

 

 

Weighted Average Exercise Price

 

 

Contractual

Life in Years

 

 

 Intrinsic

Value

 

Outstanding - November 30, 2021

 

 

1,532,500

 

 

$0.40

 

 

 

1.02

 

 

 

 

Exercisable - November 30, 2021

 

 

1,532,500

 

 

$0.40

 

 

 

1.02

 

 

$-0-

 

Granted

 

 

-0-

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised or Vested

 

 

-0-

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited or Expired

 

 

300,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding - May 31, 2022

 

 

1,232,500

 

 

$0.40

 

 

 

.52

 

 

 

 

 

Exercisable - May 31, 2022

 

 

1,232,500

 

 

$0.40

 

 

 

.52

 

 

$-0-

 

 

As of May 31, 2022, the Company has no outstanding warrants. All the outstanding warrants have expired.

 

NOTE 5. RELATED PARTY TRANSACTIONS

 

On October 15, 2021, a Promissory Note was issued to Anthony Pallante, Chairman and a significant stockholder of the Company. The Note is unsecured and was issued in consideration for payments made by Mr. Pallante on behalf of the Company to creditors in satisfaction of Company obligations. Mr. Pallante loaned the Company $20,101. The Note bears Interest at a rate of 8% per annum. All unpaid principal and accrued interest shall be due and payable upon demand by the Holder at any time subsequent to six (6) months from the date the notes were issued. As of May 31, 2022, Mr. Pallante made additional payments of $37,036 for a total of $57,137.

 

NOTE 6. CONVERTIBLE DEBT

 

On January 29, 2015, the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2,300,000 of senior secured convertible debentures, convertible into shares of the Company’s common stock.

 

The Company received $1,800,000 of the funds from the transaction on February 5, 2015. The balance of $500,000 was received on May 14, 2015. These convertible notes were subsequently acquired by Fengate Trident, LP (‘Fengate”) on April 28, 2017.

 

The convertible debentures are convertible into shares of the Company’s common stock at an initial conversion price of $0.71 per share, for an aggregate of up to 3,239,437 shares. The debentures originally accrued interest at 6% per annum. On September 26, 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer, sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30, 2019. We considered ASC Topic 470-50, Debt Modifications and Extinguishments, and determined that the modification was not deemed substantial.

 

Due to the note being convertible to common shares of the Company, a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647,888 which was recognized as debt discount. As of November 30, 2017, the full amount of the debt discount has been amortized.

 

On September 26, 2016, the Company entered into a securities purchase agreement with a non-US institutional investor, pursuant to which, in consideration for proceeds of $4,100,000, the Company issued a secured convertible promissory note in the amount of $4,100,000. Pursuant to the securities purchase agreement, the investor has agreed, from time to time after January 1, 2017, to make additional investments at the Company’s request of up to $5,900,000. On May 9, 2017, the Company received the second tranche of funding with proceeds of $4,400,000 and on May 16, 2018 the third tranche of $1,500,000 for a total investment by the investor of $10,000,000.

 

The Company used the proceeds of the secured convertible note for general working capital purposes including settlement of accounts payable and repayment of mature loans.

 

 
12

Table of Contents

 

In consideration of each advance made by the investor pursuant to the securities purchase agreement, the Company issued to the investor a convertible promissory note of equal value, maturing on September 30, 2019, and bearing interest at the rate of 8% per annum. Each note was secured in first priority against the present and after acquired assets of the Company and was convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price of $0.60 per share, for an aggregate of up to 16,666,667 shares. These convertible notes were subsequently acquired by Fengate on April 28, 2017.

 

Due to the notes being convertible to common shares of the Company, a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature of the notes amounted to $3,333,334 and was recognized as a debt discount. As of November 30, 2021, $3,333,334 of the debt discount was amortized to interest of which $334,988 was amortized during the current year compared to $855,987 in the prior year. As of November 30, 2021, the debt discount was fully amortized.

 

On November 30, 2018 the Company and Fengate entered into a Securities Purchase Amendment Agreement ("SPS") pursuant to which the Company has agreed to issue to Fengate additional convertible promissory notes (collectively, the “2018 and 2019 Convertible Notes”) of up to $10,000,000, subject to certain terms and conditions. Each portion of the principal amount advanced pursuant to the SPA boar interest at the rate of twelve percent (12%) per annum and will be payable monthly in arrears to Fengate. Outstanding principal and interest will continue to be secured by the general security agreement dated September 26, 2016, which forms a part of the Agreement. The holder of the note may also elect from time to time to convert all or a portion of the outstanding principal and interest into common shares of the Company at a 25% discount to the average closing price of the common shares during the 10 trading days immediately prior to the applicable conversion date. The 2018 and 2019 Convertible Notes (aka “Amended SPA Notes”) were extended until December 1, 2021. The Maturity Date of the Amended SPA Notes was extended to November 30, 2025, as described below.

       

On November 30, 2018 the Company received the first tranche of funding with proceeds of $3,400,780. The 2nd tranche of $2,804,187 was received on April 13, 2019. The 3rd tranche of $3,795,033 less $936,168 withheld for interest payments up to and including June 30, 2020 was received on November 6, 2019. On March 5, 2020, the 2018 and 2019 Convertible Notes were amended to increase the amount of the 3rd tranche by $936,168 representing the amount previously withheld as interest payment. The withheld interest was subsequently received on March 12, 2020.

 

The Company analyzed the embedded conversion option on the convertible notes for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option on the 2018 Convertible Note qualified for derivative accounting. The Company used the Black-Scholes model to value the embedded conversion option at $892,000 on the issuance date of November 30, 2018, $1,911,256 on the issuance date of April 13, 2019 and $1,696,933 on the issuance date of November 6, 2019. The assumptions used were a discount rate of 2.80%, 1.96% and 1.96%; volatility rate of 79.57%, 104.70% and 107.3%; and a term of 1.50, 1.13 and 0.57 years respectively. The fair values of the embedded conversion options were recorded as debt discount and were amortized over the term of the 2018 and 2019 Convertible Notes. Amortization of debt discount for the years ended November 30, 2021 and 2020 was $1,885,587 and $1,857,295, respectively. The unamortized discount as of November 30, 2021 is $0.

 

On January 9, 2020 the Company and Fengate entered into an Amendment to Convertible Promissory Notes Agreement to amend the terms of the convertible notes issued on February 5, 2015 (US$1,800,000), May 14, 2015 (US$500,000), September 26, 2016 (US$4,100,000), May 9, 2017 (US$4,400,000) and May 16, 2018 (US$1,500,000) (collectively the “2016 Convertible Notes”). Pursuant to the Amendment, Fengate has agreed to convert all of the 2016 Notes on or before the earlier to occur of (i) the maturity date of the 2016 Convertible Notes and (ii) the Company raising new equity investment of not less than US$2,000,000, on terms mutually acceptable to Fengate and the Company (subject to Fengate’s regulatory considerations). Conversion of the 2016 Notes will occur in a single conversion transaction at a price that is equal to a 25% discount to the average closing price of the Company’s common stock for the 10 trading days immediately prior to the conversion date, with the exact structure of the conversion to be determined by the parties. On June 3, 2020 the maturity date was extended from May 31 to December 31, 2020. The Amendment also extended the maturity date of the 2018 and 2019 Convertible Notes to December 1, 2021.

 

The Company analyzed the embedded conversion option on the amended “2016 Convertible Notes” for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option qualified for derivative accounting. On January 9, 2020 the Company used the Black-Scholes model to value the embedded conversion options at $7,965,083. The assumptions used were a discount rate of 1.96%, volatility rate of 148.8%; and a term of 0.39 years respectively. The modification resulted in $3,981,221 of APIC previously recorded for beneficial conversion feature of these convertible notes being reclassified as derivative liability.

 

On November 30, 2020, the Company entered into a fourth amendment of the 2016 Convertible Notes and the 2018 and 2019 Convertible Notes wherein the Company will issue to Fengate 29,432,320 shares of Company Preferred Stock (representing $17,659,392 of principal and interest converted into Preferred Stock at the rate of $0.60 per share), in full and complete satisfaction of (i) all amounts owing under the 2016 Convertible Notes through November 30, 2021 (including accrued interest thereon) and (ii) all accrued interest on the 2018 and 2019 Convertible Notes through November 30, 2021. The conversion was originally expected to occur by the end of June, 2021. The 2018 and 2019 Convertible Notes were further amended to (i) eliminate the conversion feature of such notes, (ii) provide for a simple interest rate of 8% per annum, with the first 2 years of interest payable at maturity of the 2018 and 2019 Convertible Notes and the last three years of interest payable quarterly beginning February 28, 2023; and (iii) extend the maturity of such notes until November 30, 2025. Pursuant to this amendment, all notes no longer qualified for derivative accounting. As such, the value of the embedded conversion options of all notes of $5,494,363 was credited to additional paid in capital.

 

The consummation of the foregoing transaction is subject to (i) authorization and issuance of the Preferred Stock, which is subject to approval of the requisite number of common shares of the Company, in accordance with Nevada law and the Company’s organizational documents, and (ii) Note Holder’s obligation to remain in compliance with regulations governing its ownership of voting shares.

 

 
13

Table of Contents

 

The Company and Note Holder had previously undertaken to consummate the foregoing transactions no later than June 30, 2021. On March 29, 2022, the Board of Directors approved an amendment to our Certificate of Incorporation which authorizes 29,432,320 shares of Company Preferred Stock. On March 30, 2022, more than a majority in interest of our common shares by written consent approved such amendment to our Certificate of Incorporation. The effectiveness of this shareholder approval is pending the filing of an information statement with the SEC and mailing to our shareholders. The Company expects to consummate this transaction prior to September 30, 2022

 

We considered ASC Topic 470-50, Debt Modifications and Extinguishments in connection with the amendment of the interest rate and maturity date of the 2018 and 2019 Convertible Notes and determined that the modification would be considered a debt extinguishment. The unamortized discount of $1,092,295 at the date of amendment was recognized as a loss on debt extinguishment for the year ended November 30, 2020

 

NOTE 7. NON-CONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR, INC.

 

On March 30, 2021, a non-US investor subscribed to the acquisition of 333,333 units of the Company’s Brain Armor Inc subsidiary. Each unit is comprised of one share of Brain Armor stock, $0.001 par value and a common stock purchase warrant evidencing the right to purchase one share of Common Stock. The 333,333 units were sold at a per unit price of USD $0.30 for an aggregate purchase price of USD $100,000 which was received by the Company on March 30, 2021. The vesting and exercise prices of the warrants are as follows:

 

 

1/3 of shares shall be exercisable 6 months after the subscription date at an exercise price of $0.45 per share

 

1/3 of shares shall be exercisable 12 months after the subscription date at an exercise price of $0.60 per share

 

1/3 of shares shall be exercisable 18 months after the subscription date at an exercise price of $0.75 per share

 

On May 5, 2021, a US investor subscribed to the acquisition of 3,333,333 units of the Company’s Brain Armor Inc subsidiary, with each unit being comprised of one share of Brain Armor stock, $0.001 par value and a common stock purchase warrant evidencing the right to purchase one share of Common Stock at a per unit price of USD $0.30 for an aggregate purchase price of USD $1,000,000 of which $100,000 was received by the Company on May 13, 2021 and $100,000 on May 27, 2021. This subscription agreement has since been terminated by mutual agreement of Brain Armor Inc. and the investor.

 

The vesting and exercise prices of the warrants are as follows:

 

 

1/3 of shares shall be exercisable 6 months after the subscription date at an exercise price of $0.45 per share

 

1/3 of shares shall be exercisable 12 months after the subscription date at an exercise price of $0.60 per share

 

1/3 of shares shall be exercisable 18 months after the subscription date at an exercise price of $0.75 per share

 

 
14

Table of Contents

 

NOTE 8. COMMITMENTS AND CONTINGENCIES

 

Everlast License Agreement

 

On December 23, 2013, the Company entered into a Deed of Assignment Agreement with Everlast World’s Boxing Headquarters Corporation, International Brand Management Limited, Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast, International Brand, Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition, a New York corporation, has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement, Sports Nutrition Products Incorporated, a wholly owned subsidiary of Trident Brands Incorporated, assigned all of its rights, title, interest and benefit to the trade mark license to the Company effective December 23, 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary, Sports Nutrition Products Inc.

 

The Everlast License Agreement includes a clause stating that Manchester Capital Incorporated will guarantee that the Licensee shall perform all of its obligations and duties under the License Agreement. If the Licensee defaults in the payment when due of any amount it is obliged to pay to Licensor under the License Agreement, or arising from its termination, Manchester Capital is unconditionally responsible to pay that amount to Licensor in the manner prescribed in the License Agreement as if it were the Licensee.

 

The Royalty Calculation, as per the terms of the agreement, are as follows: In 2013, 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014, 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015, 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards, 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed Royalty is $120,000 in 2014, $235,000 in 2015, $320,000 in 2016, $345,000 in 2017 and in 2018 onwards, if the Agreement remains in force, will be 75% of the previous Year’s Royalty Calculation or the previous Year’s Annual Minimum Guaranteed Royalty plus 10%, whichever is greater. 

 

The agreement was terminated on December 31, 2017. On January 17, 2019, Everlast World’s Boxing Headquarters Corp. (“Everlast”) filed a counter claim against the Company and other defendants. In that lawsuit, Everlast seeks payment from the defendants under a License Agreement dated June 4, 2013, for $425,555 in unpaid royalties allegedly due and owing under the License Agreement and interest on the allegedly unpaid royalties of $96,265, which interest allegedly continues to accrue. Everlast has also sought all costs, expenses, and legal fees incurred by Everlast in collecting monies that it claims are due under the License Agreement. On February 26, 2020, the court in the Everlast matter issued an Opinion and Order granting a motion to dismiss all of the Company’s claims against Everlast and granting a motion for judgment on the pleadings as to liability against the Company. The Court left open the question of damages to be awarded to Everlast. The Company had requested that the parties participate in settlement discussions before a magistrate judge or, in the alternative, that Everlast engage in limited discovery on these matters. No settlement was reached. On October 15, 2020, the Court in the Everlast case ordered, adjudged and decreed that Plaintiff Everlast have judgment and recover a total of $738,946 from the Company as follows:

 

1. $425,000 representing royalty payments due to Everlast;

2. Interest on royalty payments computed through October 15, 2020, in the sum of $242,920;

3. Costs and attorneys’ fees in the sum of $71,026

  

On November 17, 2021, The Company entered Into a Stipulation (“Stipulation”) of the litigation captioned Everlast World’s Boxing Headquarters Corp. (“Everlast”) , Plaintiff vs. Trident Brands, Inc. and Manchester Capital Inc., Defendants, Waukesha County Court Case No. 21 TJ 90.  Under the terms of the Stipulation, the Company agreed to pay Everlast on or before February 15, 2022, the sum of $650,000 in full satisfaction of the Everlast’s judgment against the Company in the amount of $738,946. Under the Stipulation, except for the first $250,000 of capital raised, the Company is required to pay Everlast 20% of the gross amount of any capital raising transaction, until the full $650,000 is paid, provided however that the full $650,000 was required to have been paid no later than February 15, 2022.   

 

The Company failed to pay Everlast the full $650,000 by February 15, 2022, as a result of which the Company is obligated to pay Everlast the judgment amount of $738,945, plus applicable interest (a total of $750,713 as of August 21, 2021) and attorney’s fees, less any payments made. The estimated liability as of May 31, 2022 due to accrued interest is $908,799 which the Company has fully accrued. The Company is currently in litigation with Everlast regarding Everlast's methods to collect the judgements.

 

Banc of America Leasing and Capital 

 

On December 1, 2020, Bank of America Leasing and Capital, LLC filed a legal action against the Company in the Superior Court for the State of California, County of San Mateo (Case NO. 20-CIV-05306), alleging breach of contract. The claim arises out of a software services contract between the Company and Oracle Corporation. Bank of America Leasing and Capital, LLC acquired Oracle’s rights under the agreement. The plaintiff claims the Company is liable for damages in the amount of $217,000 plus interests and costs. The Company has not filed an answer to this complaint. On February 22, 2021, the plaintiff requested that the Court enter a default judgment against the Company. The Company intends to engage counsel and defend against this claim.

 

 
15

Table of Contents

 

PIT Mycell

 

On June 3, 2019, the Company filed a lawsuit against PIT Mycell, LLC, William E. Peterson III, New Age Ventures, LLC, Volker Berl, and Mycell Technologies, LLC (“Mycell”) in the Superior Court in Bergen County, New Jersey, Civil Action No. BER-L-004198-19, in which the Company seeks to require the defendants to perform under and allow the enforcement of certain notes made by Mycell and acquired by the Company in September 2017. The notes are past their stated maturity date of December 31, 2016. The Company also alleges that the parties had entered into a written Settlement Agreement Letter of Intent dated March 14, 2019 (the “Settlement”), but that the defendants repudiated it shortly thereafter. The notes had been the subject of an earlier lawsuit in Virginia in state court in Fairfax County between the Company and PIT Mycell, LLC that the Settlement was intended to resolve. The Company seeks to enforce the notes and the Settlement in the New Jersey lawsuit and requests actual damages in an amount to be proven at trial, attorneys’ fees and litigation costs, specific performance requiring certain defendants to enforce obligations under the notes against Mycell, specific performance requiring the defendants to execute a final Settlement Agreement consistent with the Settlement, an order permitting foreclosure on the collateral for the notes, and declaratory relief. On January 24, 2020, the New Jersey court denied Defendant’s Motions to dismiss the case. The parties have engaged in written discovery and exchanged productions of documents. Mycell filed for bankruptcy on November 25, 2020. The bankruptcy is completed and the Company no longer has a claim on the new company that has since emerged from bankruptcy.

 

Contingencies

 

The Company may be subject to various legal proceedings and claims that arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. There is significant judgment required in both the probability determination and as to whether an exposure can be reasonably estimated. If any legal matter, that may arise, were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s would reflect any potential claim in the consolidated financial statements for that reporting period.

 

NOTE 9. SUBSEQUENT EVENTS

 

On March 3, 2022, the Board authorized the following executive compensation plan:

 

 

-

Upon the closing of an initial financing (greater than $2,000,000) then the CEO shall be issued 1.5% of the fully diluted common stock and the Chairman shall receive 1.0% of the fully diluted common stock;

 

 

 

 

-

Upon the uplisting of the Company to the New York Stock Exchange (NYSE) or the Nasdaq (whether by merger or operations), then the CEO shall be issued 1.5% of the fully diluted common stock and the Chairman shall receive 1.0% of the fully diluted common stock;

 

 

 

 

-

Upon the closing of an acquisition, then the CEO shall be issued a bonus equal 3% of the total enterprise value of the deal and the Chairman shall receive 2% of the total enterprise value of the deal, which may at the option of the Company be paid in cash, or stock. If the bonus is paid in stock, then the stock shall be issued at a 20% discount to the market;

 

The Company's Board of Directors also established the following compensation and bonus plan for its CEO and reserved some bonus stock in anticipation of hiring a COO and CFO:

 

Total Revenue* (in millions)

 

 

Adjusted EBITDA*

 

 

Exercise Price**

 

 

Percent of Shares

CEO ***

 

 

Percent of Shares

COO***

 

 

Percent of Shares

CFO***

 

$

1.00

 

 

 

N/A

 

 

$

0.05

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

2.00

 

 

 

N/A

 

 

$

0.125

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

4.00

 

 

 

N/A

 

 

$

0.25

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

8.00

 

 

$

80,000

 

 

$

0.50

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

12.00

 

 

$

150,000

 

 

$

0.75

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

18.00

 

 

$

225,000

 

 

$

1.00

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

30.00

 

 

$

450,000

 

 

$

1.50

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

45.00

 

 

$

675,000

 

 

$

2.50

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

75.00

 

 

$

1,312,500

 

 

$

5.00

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

 

* Until the Company achieves the $8 million revenue target, the executive will earn 100% of eligible shares upon attainment of the relevant revenue target.  Commencing with achievement of the $8 million revenue target, the executive will earn 75% of the eligible shares upon attainment of the revenue target and will earn 25% of the eligible shares upon attainment of the Adjusted EBITDA target.

** Exercise Price shall be the lower of the Exercise Price set forth above or a 20% discount to the 5-day VWAP

** Exercise Price shall not be adjusted accordingly for any stock splits, as these Exercise Prices are after giving effect to the split.

*** Percent of Shares shall be based on the number of fully diluted common shares

 

On March 3, 2022, the Board also authorized the award of 4,000,000 shares to the Company's employees. The shares will be vested immediately and issued all at once.  

 

On April 4, 2022, the Company announced that it filed an amendment to its certificate of incorporation to: (1) authorize 29,320,432 shares of Preferred Stock which it will use to satisfy approximately $17.7 Million of principal and accrued interest due under certain convertible notes, representing a conversion rate of $0.60 per share, and (2) change the name of the corporation to SOLNI Group. The amendment authorizing the Preferred Shares was approved by a majority of the Company’s shareholders and was filed with the State of Nevada on March 31, 2022. The amendments are expected to be effective by September 30, 2022.  

 

 
16

Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS

 

Forward Looking Statements

 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the interim consolidated financial statements, and notes thereto, for the quarter ended May 31, 2022 contained under Item 1 of this Quarterly Report on Form 10-Q (“Form 10-Q”) and in conjunction with the annual consolidated financial statements, and notes thereto, contained in the Annual Report on Form 10-K for the fiscal year ended November 30, 2021 (“Form 10-K”). Unless otherwise indicated herein, the discussion and analysis contained in this MD&A includes information available through July 27, 2022.

 

Certain statements contained in this MD&A may constitute forward-looking statements as defined under securities laws. Forward-looking statements may relate to our future outlook and anticipated events or results and may include statements regarding our future financial position, business strategy, budgets, litigation, projected costs, capital expenditures, financial results, taxes, plans and objectives. In some cases, forward-looking statements can be identified by terms such as “anticipate”, “estimate”, “intend”, “project”, “potential”, “continue”, “believe”, “expect”, “could”, “would”, “should”, “might”, “plan”, “will”, “may”, “predict”, the negatives of such terms, and other similar expressions concerning matters that are not historical facts. To the extent any forward-looking statements contain future-oriented financial information or financial outlooks, such information is being provided to enable a reader to assess our financial condition, material changes in our financial condition, our results of operations, and our liquidity and capital resources. Readers are cautioned that this information may not be appropriate for any other purpose, including investment decisions.

 

Forward-looking statements contained in this MD&A are based on certain factors and assumptions regarding expected growth, results of operations, performance, and business prospects and opportunities. While we consider these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Forward-looking statements are also subject to certain factors, including risks and uncertainties that could cause actual results to differ materially from what we currently expect. These factors are more fully described in the “Risk Factors” section at Item 1A of the Form 10-K.

 

Forward-looking statements contained in this commentary are based on our current estimates, expectations and projections, which we believe are reasonable as of the date of this report. You should not place undue importance on forward-looking statements and should not rely upon this information as of any other date. Other than as required under securities laws, we do not undertake to update any forward-looking information at any particular time.

 

All dollar amounts in this MD&A are expressed in thousands of U.S. dollars unless otherwise noted.

 

Results of Operations

 

The following summary of our results of operations should be read in conjunction with our unaudited consolidated financial statements for the three and six month periods ended May 31, 2022 and May 31, 2021.

 

 
17

Table of Contents

 

Our operating results for three month periods ended May 31, 2022 and May 31, 2021 are summarized as follows:

 

 

 

Three

Months Ended

 

 

Three

Months Ended

 

 

 

May 31,

 

 

May 31,

 

 

 

2022

 

 

2021

 

 

 

 

 

 

 

 

Revenues

 

$125,280

 

 

$46,243

 

Gross Profit

 

$(21,168)

 

$21,663

 

Operating Expenses

 

$528,103

 

 

$537,978

 

Other Expenses

 

$234,170

 

 

$200,008

 

Net Loss

 

$(783,441)

 

$(716,323)

 

 

 

 

 

 

 

 

 

Add back:

 

 

 

 

 

 

 

 

Interest Expense

 

$234,170

 

 

$200,008

 

Depreciation

 

$-0-

 

 

$-0-

 

Amortization

 

$-0-

 

 

$-0-

 

 

 

 

 

 

 

 

 

 

EBITDA

 

$(549,271)

 

$(516,315)

 

Revenues and Gross Profits

  

Sales for the three month period ended May 31, 2022 increased to $125,280 versus $46,243 in the prior period. The increase was the result of a special sale of raw material. Gross profit decreased to $(21,168) versus $21,663 or 46.8% of revenues. Other than this special sales of raw material, we currently have no revenue. If we are able to secure sufficient additional funding and needed inventory, we expect that our revenues will gradually recover. In addition, we intend to continue to look for distribution and supply chain partners to lower our costs.

 

Operating Expenses

 

Our operating expenses for the three month period ended May 31, 2022 and May 31, 2021 are summarized below:

 

 

 

Three

Months Ended May 31,

 

 

Three

Months Ended May 31,

 

 

 

2022

 

 

2021

 

Professional Fees

 

$46,341

 

 

$80,478

 

General & Administrative Expenses

 

$454,073

 

 

$422,304

 

Marketing, Selling & Warehousing Expenses

 

$8,477

 

 

$34,451

 

Director’s Fees

 

$18,000

 

 

$-0-

 

Rent

 

$1,212

 

 

$745

 

 

Operating expenses for the three month period ended May 31, 2022 were $528,103 as compared to $537,978 for the comparable period in 2021, a decrease of 1.8%. The decrease in our operating expenses was primarily due to a decrease in general & administrative expenses as a result of cost reductions and decreased marketing and selling expenses related to the decrease in sales. General & administrative expenses included a compensation expense of $120,000 for the authorized award of 4,000,000 shares to the Company's employees. Subject to raising additional capital, we expect our operating expenses to increase as we ramp up our selling activities.

 

 
18

Table of Contents

 

Other Expenses

 

Other expenses for the three month period ended May 31, 2022 were $234,170 as compared to $200,008 for the comparable period in 2021, an increase of 1.2%. The increase of $34,162 was primarily due to an additional accrual of $29,726 for the Everlast liability. We expect interest expenses to remain constant.

 

Six Month Periods Ended May 31, 2022 and May 31, 2021

 

Our operating results for six month periods ended May 31, 2022 and May 31, 2021 are summarized as follows:

 

 

 

Six

Months Ended

May 31,

2022

 

 

Six

Months Ended

May 31,

2021

 

 

 

 

 

 

 

 

Revenues

 

$125,280

 

 

$190,291

 

Gross Profit

 

$(21,168 )

 

$86,923

 

Operating Expenses

 

$945,412

 

 

$942,262

 

Other Expenses

 

$569,846

 

 

$400,341

 

Net Loss

 

$(1,536,426 )

 

$(1,255,680 )

 

 

 

 

 

 

 

 

 

Add back:

 

 

 

 

 

 

 

 

Interest Expense

 

$569,846

 

 

$400,341

 

Depreciation

 

$-0-

 

 

$-0-

 

Amortization

 

$-0-

 

 

$-0-

 

 

 

 

 

 

 

 

 

 

EBITDA

 

$(966,580 )

 

$(855,339 )

 

Revenues and Gross Profits

  

Sales for the six month period ended May 31, 2022 decreased to $125,280 versus $190,291 in the prior period. The decrease was due in part to the lack of inventory (out of stock of certain SKU’s), which also prevented us from fulfilling various purchase orders. Our lack of inventory is a result of not having sufficient capital to purchase inventory. Subject to receipt of additional funding, we expect this lack of supply to resolve over the next three months, at which time we expect our sales will begin to recover. Gross profit decreased to $(21,168) or (-16.9% of revenues) versus $86,923 (45.7% of revenues). We currently have no revenue. If we are able to secure sufficient additional funding and needed inventory, we expect that our revenues will gradually recover. In addition, we intend to continue to look for distribution and supply chain partners to lower our costs.

 

 
19

Table of Contents

  

Operating Expenses

 

Our operating expenses for the six month period ended May 31, 2022 and May 31, 2021 are summarized below:

 

 

 

Six

Months Ended

May 31,

2022

 

 

Six

Months Ended

May 31,

2021

 

Professional Fees

 

$

92,717

 

 

$

94,127

 

General & Administrative Expenses

 

$

805,232

 

 

$

869,750

 

Marketing, Selling & Warehousing Expenses

 

$

26,277

 

 

$

61,481

 

Director’s Fees

 

$

18,000

 

 

$

 -0-

 

Rent

 

$

3,186

 

 

$

1,904

 

 

Operating expenses for the six month period ended May 31, 2022 were $945,412 as compared to $942,262 for the comparable period in 2021, an increase of .3%. The increase in our operating expenses was primarily due to a compensation expense of $120,000 for the authorized award of 4,000,000 shares to the Company's employees and director's fees of $18,000 which offset a decrease in general & administrative expenses as a result of cost reductions and decreased marketing and selling expenses related to the decrease in sales. Subject to raising additional capital, we expect our operating expenses to increase as we ramp up our selling activities.

 

Other Expenses

 

Other expenses for the six month period ended May 31, 2022 were $569,846, compared to $400,341 in the comparable period in 2021. The increase of $169,505 was primarily due to an additional accrual of $169,854 for the Everlast liability. We expect interest expenses to remain constant.

 

Balance Sheet Data

 

The following table provides selected balance sheets data as at May 31, 2022 and November 30, 2021.

 

Balance Sheet Data:

 

May 31,

2022

 

 

November 30,

2021

 

 

 

 

 

 

 

 

Cash

 

$12,389

 

 

$7,653

 

Total assets

 

$749,357

 

 

$1,060,081

 

Total liabilities

 

$33,335,742

 

 

$32,230,040

 

Stockholders’ (deficit)

 

$(32,586,385 )

 

$(31,169,959 )

 

Strategic Orientation

 

Our objective is to provide our shareholders with solid returns through strategic investments across multiple consumer product and ingredient platforms. The platforms we are focusing on include:

 

 

Life science technologies and related products that have applications to a range of consumer products;

 

Nutritional supplements and related consumer goods providing defined benefits to the consumer; and

 

Functional foods and beverages ingredients with defined health and wellness benefits.

 

 
20

Table of Contents

 

We are building our business through strategic investments in high growth early stage consumer brands and functional ingredient platforms within segment/sectors which we believe offer sustainable commercial potential. We are focused on three core strategies underpinning our objectives:

 

 

To execute a multi-tier brand, supply-chain and innovation strategy to drive revenue; and

 

To aggressively manage an asset light business model to drive a low cost platform.

 

While we have yet to achieve profitability, we are endeavoring to make progress against our long term commercial objectives. Subject to receipt of sufficient capital, which we currently do not have, we anticipate that revenue and margin will increase as we strengthen distribution partnerships while capitalizing on product innovation, supply-chain optimization and brand equity within our current portfolio.

 

Liquidity and Capital Resources

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.

 

As of May 31, 2022, the Company had $12,389 in cash and a working capital deficit of $10,286,385. The Company also has generated losses and has an accumulated deficit as of May 31, 2022. These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the next 12 months. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Need for Additional Capital

 

The current funds available to the company are not sufficient to fund its near term operations. The Company has an urgent need for additional capital, without which, the Company is unlikely to continue as a going concern. Unless management is able to obtain additional financing, the Company will not be able to meet its funding requirements during the next 12 months. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

As of May 31, 2022, the Company had $12,389 in cash and a working capital deficit of $10,286,385, compared to a deficit of approximately $8.9 million as of November 30, 2021 The approximate $1.4 million increase in working capital deficit was due primarily to an increase in accrued liabilities of $1.1 million, a decrease in prepaids of $0.2 million and a decrease in inventory of $0.1 million.

 

As disclosed under Item 3. Legal Proceedings, a judgment was entered against us in the Everlast matter in the amount of approximately $740,000, which has grown to more than $900,000 as of May 2022. In addition, the plaintiff in the Oracle matter has requested a default judgment against us. Accordingly, the Company is currently obligated to pay Everlast approximately $750,000 not including interest accrued since August 2021 and could be liable to pay Oracle at least $217,000 if the court enters a default judgment, in which case, the Company would be liable for in excess of $1 million in judgments, in the aggregate. If the Company is compelled to pay these liabilities, there would be a material adverse effect on the financial condition of the Company.

 

Because we have  only minimal cash on hand, we are unable to implement our current business plan. Accordingly, we have an immediate need for additional capital to fund our operating activities. We currently have no revenues have had difficulty raising additional capital, so there is no assurance we will be able to grow our business or raise sufficient additional capital on acceptable terms or at all.

 

In order to remedy this liquidity deficiency, we are actively seeking to raise additional funds through the sale of equity and/or debt securities, and ultimately, we will need to generate substantial positive operating cash flows. Our internal sources of funds will consist of cash flows from operations, but not until we begin to realize additional revenues from the sale of our products and services. As previously stated, our operations are generating negative cash flows, and thus adversely affecting our liquidity. If we are unable to raise additional funds in the near term, we will not be able to implement our business plan, in which case there would be a material adverse effect on our results of operations and financial condition.

 

In the event we do not generate sufficient funds from revenues or financing through the issuance of common stock or from debt financing, we will be unable to implement our business plan and pay our obligations as they become due, any of which circumstances would have a material adverse effect on our business prospects, financial condition, and results of operations. The accompanying financial statements do not include any adjustments that might be required should we be unable to recover the value of our assets or satisfy our liabilities.

 

Based on our limited availability of funds we expect to spend minimal amounts on product development, sales and marketing and capital expenditures. We expect to fund any future product development expenditures through a combination of cash flows from operations and proceeds from equity and/or debt financing. If we are unable to generate positive cash flows from operations, and/or raise additional funds (either through debt or equity), we will be unable to fund our product development expenditures, in which case, there could be material and adverse effect on our business and results of operations.

 

 
21

Table of Contents

     

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

Contractual Obligations

  

Except for the transactions disclosed in this Report, there have been no material changes outside the normal course of business in our contractual obligations since February 28, 2022.

 

Critical Accounting Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, related revenues and expenses, and disclosure of gain and loss contingencies at the date of the financial statements. The estimates and assumptions made require us to exercise our judgment and are based on historical experience and various other factors that we believe to be reasonable under the circumstances. We continually evaluate the information that forms the basis of our estimates and assumptions as our business and the business environment generally changes. The use of estimates is pervasive throughout our financial statements. There have been no material changes to the critical accounting estimates disclosed under the heading “Critical Accounting Estimates” in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, of the Form 10-K.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company we are not required to provide this information.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and the principal financial officer, we have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded as of the evaluation date that our disclosure controls and procedures were not effective such that the material information required to be included in our Securities and Exchange Commission reports is accumulated and communicated to our management, including our principal executive and financial officer, recorded, processed, summarized and reported within the time periods specified in SEC rules and forms relating to our company, particularly during the period when this report was being prepared.

 

Changes in Internal Controls Over Financial Reporting

 

Our management, with the participation of our principal executive officer and principal financial officer have concluded that there have been no changes in our internal control over financial reporting that occurred during the fiscal quarter ended May 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
22

Table of Contents

 

PART II. OTHER INFORMATION

 

 

 

 

Table of Contents

 

ITEM 6. EXHIBITS

 

The following exhibits are included with this quarterly filing:

   

Exhibit No.

 

Description

 

 

 

3.1

 

Articles of Incorporation as amended (incorporated by reference to our Annual Report on form 10-K for the year ended November 30,2021 filed with the SEC on April 14, 2022*)

 

 

 

3.2

 

Bylaws*

 

 

 

31.1

 

Sec. 302 Certification of Chief Executive Officer

 

 

 

31.2

 

Sec. 302 Certification of Chief Financial Officer

 

 

 

32.1

 

Sec. 906 Certification of Chief Executive Officer

 

 

 

32.2

 

Sec. 906 Certification of Chief Financial Officer

 

 

 

101.INS

 

Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema Document.

 

 

 

101.CAL

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document.

 

 

 

101.DEF

 

Inline XBRL Taxonomy Extension Definition Linkbase Document.

 

 

 

101.LAB

 

Inline XBRL Taxonomy Extension Labels Linkbase Document.

 

 

 

101.PRE

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document.

 

 

 

104

 

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

_________________ 

* Document is incorporated by reference and can be found in its entirety in our Registration Statement on Form SB-2, SEC File Number 333-148710, at the Securities and Exchange Commission website at www.sec.gov.

 

 
25

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Trident Brands Incorporated

 

 

 

 

Date: July 27, 2022

By:

/s/ Michael Friedman

 

 

Michael Friedman

 

 

 

(Chief Executive Officer)

 

 

 

 

 

 

By:

/s/ Peter Salvo

 

 

 

Peter Salvo

 

 

 

(Principal Financial Officer)

 

 

 
26

 

EX-31.1 2 tdnt_ex311.htm CERTIFICATION tdnt_ex311.htm

EXHIBIT 31.1

 

Certification of the Chief Executive Officer

Pursuant to 18 U.S.C. 1350

(Section 302 of the Sarbanes-Oxley Act of 2002)

 

I, Michael Friedman, certify that:

 

1.

I have reviewed this Report on Form 10-Q of Trident Brands Incorporated;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: July 27, 2022

 

/s/ Michael Friedman

 

Michael Friedman

Chief Executive Officer

 

 

EX-31.2 3 tdnt_ex312.htm CERTIFICATION tdnt_ex312.htm

EXHIBIT 31.2

 

Certification of the Chief Financial Officer

Pursuant to 18 U.S.C. 1350

(Section 302 of the Sarbanes-Oxley Act of 2002)

 

I, Peter Salvo, certify that:

 

1.

I have reviewed this Report on Form 10-Q of Trident Brands Incorporated;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: July 27, 2022

 

/s/ Peter Salvo

 

Peter Salvo

Principal Financial Officer

 

EX-32.1 4 tdnt_ex321.htm CERTIFICATION tdnt_ex321.htm

EXHIBIT 32.1

 

CERTIFICATION OF CHIEF EXECTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Trident Brands Incorporated (the “Company”) on Form 10-Q for the period ending May 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Friedman, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

IN WITNESS WHEREOF, the undersigned has executed this certification as of July 27, 2022.

 

/s/ Michael Friedman

 

Michael Friedman

Chief Executive Officer

 

 

EX-32.2 5 tdnt_ex322.htm CERTIFICATION tdnt_ex322.htm

 EXHIBIT 32.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Trident Brands Incorporated (the “Company”) on Form 10-Q for the period ending May 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peter Salvo, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

IN WITNESS WHEREOF, the undersigned has executed this certification as of July 27, 2022.

 

/s/ Peter Salvo

 

Peter Salvo

Principal Financial Officer

 

EX-101.SCH 6 tdnt-20220531.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 000004 - Statement - Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 000009 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 000010 - Disclosure - WARRANTS AND OPTIONS link:presentationLink link:calculationLink link:definitionLink 000011 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 000012 - Disclosure - CONVERTIBLE DEBT link:presentationLink link:calculationLink link:definitionLink 000013 - Disclosure - NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC link:presentationLink link:calculationLink link:definitionLink 000014 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 000015 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 000017 - Disclosure - WARRANTS AND OPTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 000018 - Disclosure - SUBSEQUENT EVENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000020 - Disclosure - GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000021 - Disclosure - WARRANTS AND OPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 000022 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000023 - Disclosure - CONVERTIBLE DEBT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000024 - Disclosure - NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 000026 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 000027 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 7 tdnt-20220531_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Ex Transition Period Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity File Number Entity Incorporation State Country Code Entity Address Address Line 1 Entity Address Address Line 2 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Entity Interactive Data Current Consolidated Balance Sheets ASSETS Current Assets Cash Accounts Receivable, net of allowance for doubtful accounts of $11,286 and $160,210, respectively Inventory, net of reserves of $401,606 and $401,606, respectively Prepaid and other current assets Total Current Assets [Assets, Current] TOTAL ASSETS [Assets] LIABILITIES & STOCKHOLDERS' DEFICIT Current Liabilities Accounts Payable Accrued Liabilities Total Current Liabilities [Liabilities, Current] Convertible Debt, net of discount of $0 and $0, respectively Total Liabilities [Liabilities] Stockholders' Deficit Common stock, $0.001 par value, 300,000,000 shares authorized; 37,311,887 and 33,311,887 shares issued and outstanding as of May 31, 2022 and November 30, 2021 respectively Additional paid-in capital Non-Controlling Interest in Subsidiary Accumulated Deficit Total Stockholders' Deficit [Stockholders' Equity Attributable to Parent] TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT [Liabilities and Equity] Allowances for account receivable Inventory, net of reserves Debt discount, convertible debt non-current Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Consolidated Statements of Operations (Unaudited) Revenues, net Cost of Sales Gross Profit [Gross Profit] General & Administrative Expenses [General and Administrative Expense] Loss from Operations [Operating Income (Loss)] Other Income (Expenses) Interest Expense, net [Interest Expense] Total Other Income (Expenses) [Other Nonoperating Income (Expense)] Net Loss [Net Income (Loss) Attributable to Parent] Net loss attributable to Trident Net loss attributable to Non-Controlling Interests Loss per share - Basic and diluted Weighted average number of common shares outstanding - Basic and diluted Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statement [Table] Statement [Line Items] Equity Components [Axis] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Non- Controlling Interest [Member] Common Stock [Member] Balance, shares [Shares, Issued] Balance, amount Net loss NCI Investment in Brain Armor Issuance of Common Shares for services, share Issuance of Common Shares for services, amount Balance, shares Balance, amount Consolidated Statements of Cash Flows (Unaudited) CASH FLOWS FROM OPERATING ACTIVITIES Net loss Adjustments to reconcile net loss to net cash used in operating activities: Issuance of Common Shares for services, amount [Proceeds from Issuance of Common Stock] Provision for bad debts Changes in operating assets and liabilities: Accounts receivable Prepaid expenses Inventory Accounts payable and accrued liabilities Cash provided by (used in) operating activities [Net Cash Provided by (Used in) Operating Activities] CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from NCI Investment in Brain Armor Cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] NET CHANGE IN CASH AND CASH EQUIVALENTS [Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect] CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD CASH AND CASH EQUIVALENTS AT END OF PERIOD Supplemental disclosure of cash flow information: Cash paid for: Income taxes Interest ORGANIZATION AND DESCRIPTION OF BUSINESS ORGANIZATION AND DESCRIPTION OF BUSINESS Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] GOING CONCERN GOING CONCERN Substantial Doubt about Going Concern [Text Block] WARRANTS AND OPTIONS WARRANTS AND OPTIONS Fair Value, Option [Text Block] RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] CONVERTIBLE DEBT CONVERTIBLE DEBT Debt Disclosure [Text Block] NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC NON-CONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR, INC. COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] SUBSEQUENT EVENTS SUBSEQUENT EVENTS Subsequent Events [Text Block] Basis of Accounting Use of Estimates and Assumptions Customer Concentration Fair Value of Financial Instruments Recent Accounting Pronouncements WARRANTS AND OPTIONS (Tables) Schedule of stock option activity Schedule of subsequent events Concentration Risk Benchmark [Axis] Customer [Axis] Revenue [Member] Accounts Receivable [Member] Customer One [Member] Customer Two [Member] Number of customers Concentration risk percentage Cash [Cash] Working capital deficit Class of Warrant or Right [Axis] Warrants and Stock Options [Member] Options, Exercisable | Beginning Balance [Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable] Options, Granted Options, Exercised or Vested Options, Forfeited or Expired Options, Outstanding | Beginning Balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number] Options, Outstanding | Ending Balance Weighted Average Exercise Price, Outstanding, Begnning Balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Weighted Average Exercise Price, Exercisable | Begnning Balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price] Weighted Average Exercise Price, Outstanding, Ending Balance Weighted Average Exercise Price, Exercisable | Ending Balance Outstanding, Contractual Life in Years | Beginning Balance Outstanding, Contractual Life in Years | Ending Balance Exercisable, Contractual Life in Years | Beginning Balance Exercisable, Contractual Life in Years | Ending Balance Exercisable Intrinsic Value | Beginning Balance [Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value] Exercisable Intrinsic Value | Ending Balance Title of Individual [Axis] Mr. Pallante [Member] Additional payment of loan Due to related party Total loan Debt instrument interest rate Short-Term Debt, Type [Axis] Financial Instrument [Axis] Long-Term Debt, Type [Axis] Plan Name [Axis] Related Party [Axis] Award Date [Axis] Vesting [Axis] Change in Accounting Estimate by Type [Axis] Convertible Debt [Member] Conversion Option [Member] 2018 Convertible Note [Member] Range One [Member] Black-Scholes Model [Member] Director [Member] Range Two [Member] Range Three [Member] 2016 Notes [Member] Securities Purchase Agreement [Member] November 6, 2019 [Member] Third Tranche [Member] November 30, 2018 [Member] First Tranche [Member] April 13, 2019 [Member, Second Tranche [Member] Re-value [Member] February 5, 2015 [Member] May 14, 2015 [Member] May 9, 2017 [Member] May 16, 2018 [Member] September 26, 2016 [Member] APIC reclassified to derivative liability Increased tranche amount Embedded conversion Beneficial conversion feature Amortized for prior year Preferred stock, shares Preferred stock shares, amount Price per share Debt extinguisment Extended maturity date Discount rate Volatility rate Preferred stock, shares authorized Proceeds from convertible debt Amortization of debt discount Principal amount of debt Intrinsic value of notes Common stock conversion, shares Bearing interest rate Interest amortized Proceeds from promissory note Additional funding amount Aggregate amount of promissory note Conversion price (in dollars per share) Interest payment Convertible note description Unamortized debt discount Amortization of debt Term Volatility Discount rate [Accrual for Environmental Loss Contingencies, Discount Rate] Black scholes model conversion option Convertible promissory notes NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC (Details Narrative) Consolidated Entities [Axis] Deferred Revenue Arrangement Type [Axis] Brain Armor Inc [Member] [Brain Armor Inc [Member]] Brain Armor Inc [Member] Subscription Arrangement [Member] Exercisable after 12 months [Member] Exercisable after 18 months [Member] Per unit price Purchase price Number of shares acquired Par value Common stock shares purchased One third warrant exercise price Reinsurer, Name [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] President And CEO [Member] Plantiff Everlast[Member] December 1, 2020 [Member] Royalty Calculation Year 2013 [Member] Royalty Calculation Year 2014 [Member] Royalty Calculation Year 2015 [Member] Royalty Calculation Year 2016 [Member] June 4, 2013 [Member] License Agreement [Member] Accrued interest liability Annual Minimum Guaranteed Royalty Description of annual minimum guaranteed royalty Litigation settlement, amount Capital raised, amount Percentage of gross amount to pay for capital raising transaction, until the full amount paid Recovery, amount Payment due Ineterest royalty payment Cost and attorney's fees Final obligation to pay after default as of Aug, 21, 2021 Cost for damages Percentage of net retail sales Percentage of direct response sales revenue Payment of unpaid royalties Payment of unpaid interest Exercise Price Range Five [Member] Exercise Price Range Seven [Member] Exercise Price Range Six [Member] Exercise Price Range Four [Member] Exercise Prices Range Three [Member] Exercis Price Range Eight [Member] Exercises Price Range Nine [Member] Exercise Price Range One [Member] Exercise Price Range Two [Member] Percent of Shares CEO Total Revenue Exercise Price Percent of Shares COO Percent of Shares CFO Adjusted EBITDA Preferred stock, shares Principal and accrued interest Conversion price (in dollars per share) Subsequent description Authorized shares to employees Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the s EX-101.CAL 8 tdnt-20220531_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 9 tdnt-20220531_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 10 tdnt-20220531_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE GRAPHIC 11 tdnt_10qimg1.jpg begin 644 tdnt_10qimg1.jpg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htm IDEA: XBRL DOCUMENT v3.22.2
Cover - shares
6 Months Ended
May 31, 2022
Jul. 27, 2022
Cover [Abstract]    
Entity Registrant Name TRIDENT BRANDS INCORPORATED  
Entity Central Index Key 0001421907  
Document Type 10-Q  
Amendment Flag false  
Current Fiscal Year End Date --11-30  
Entity Small Business true  
Entity Shell Company false  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Document Period End Date May 31, 2022  
Entity Filer Category Non-accelerated Filer  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2022  
Entity Ex Transition Period false  
Entity Common Stock Shares Outstanding   37,311,887
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-53707  
Entity Incorporation State Country Code NV  
Entity Address Address Line 1 433 Plaza Real  
Entity Address Address Line 2 Suite 275  
Entity Address City Or Town Boca Raton  
Entity Address State Or Province FL  
Entity Address Postal Zip Code 33432  
City Area Code 561  
Local Phone Number 962-4122  
Entity Interactive Data Current Yes  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets - USD ($)
May 31, 2022
Nov. 30, 2021
Current Assets    
Cash $ 12,389 $ 7,653
Accounts Receivable, net of allowance for doubtful accounts of $11,286 and $160,210, respectively 1,073 12,358
Inventory, net of reserves of $401,606 and $401,606, respectively 735,476 881,924
Prepaid and other current assets 419 158,146
Total Current Assets 749,357 1,060,081
TOTAL ASSETS 749,357 1,060,081
Current Liabilities    
Accounts Payable 549,941 524,207
Accrued Liabilities 10,485,801 9,405,833
Total Current Liabilities 11,035,742 9,930,040
Convertible Debt, net of discount of $0 and $0, respectively 22,300,000 22,300,000
Total Liabilities 33,335,742 32,230,040
Stockholders' Deficit    
Common stock, $0.001 par value, 300,000,000 shares authorized; 37,311,887 and 33,311,887 shares issued and outstanding as of May 31, 2022 and November 30, 2021 respectively 37,312 32,312
Additional paid-in capital 11,608,630 11,492,630
Non-Controlling Interest in Subsidiary (633,495) (490,852)
Accumulated Deficit (43,598,832) (42,205,049)
Total Stockholders' Deficit (32,586,385) (31,169,959)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT $ 749,357 $ 1,060,081
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Balance Sheets (Parenthetical) - USD ($)
May 31, 2022
Nov. 30, 2021
Consolidated Balance Sheets    
Allowances for account receivable $ 11,286 $ 160,210
Inventory, net of reserves 401,606 401,606
Debt discount, convertible debt non-current $ 0 $ 0
Common stock, shares par value $ 0.001 $ 0.001
Common stock, shares authorized 300,000,000 300,000,000
Common stock, shares issued 37,311,887 33,311,887
Common stock, shares outstanding 37,311,887 33,311,887
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
May 31, 2022
May 31, 2021
May 31, 2022
May 31, 2021
Consolidated Statements of Operations (Unaudited)        
Revenues, net $ 125,280 $ 46,243 $ 125,280 $ 190,291
Cost of Sales 146,448 24,580 146,448 103,368
Gross Profit (21,168) 21,663 (21,168) 86,923
General & Administrative Expenses (528,103) (537,978) (945,412) (942,262)
Loss from Operations (549,271) (516,315) (966,580) (855,339)
Other Income (Expenses)        
Interest Expense, net (234,171) (200,008) (569,846) (400,341)
Total Other Income (Expenses) (234,171) (200,008) (569,846) (400,341)
Net Loss (783,442) (716,323) (1,536,426) (1,255,680)
Net loss attributable to Trident (703,825) (646,092) (1,393,783) (1,181,590)
Net loss attributable to Non-Controlling Interests $ (79,617) $ (70,231) $ (142,643) $ (74,090)
Loss per share - Basic and diluted $ (0.02) $ (0.02) $ (0.04) $ (0.04)
Weighted average number of common shares outstanding - Basic and diluted 37,181,452 32,311,887 35,267,931 32,311,887
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Total
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Non- Controlling Interest [Member]
Common Stock [Member]
Balance, shares at Nov. 30, 2020         32,311,887
Balance, amount at Nov. 30, 2020 $ (28,418,483) $ 11,458,630 $ (39,522,278) $ (387,147) $ 32,312
Net loss (539,357) 0 (535,498) (3,859) $ 0
Balance, shares at Feb. 28, 2021         32,311,887
Balance, amount at Feb. 28, 2021 (28,957,840) 11,458,630 (40,057,776) (391,006) $ 32,312
Net loss (716,323) 0 (646,091) (70,231) $ 0
NCI Investment in Brain Armor 300,000     300,000  
Balance, shares at May. 31, 2021         32,311,887
Balance, amount at May. 31, 2021 (29,374,162) 11,458,630 (40,703,867) (161,237) $ 32,312
Balance, shares at Nov. 30, 2021         33,311,887
Balance, amount at Nov. 30, 2021 (31,169,959) 11,492,630 (42,205,049) (490,852) $ 33,312
Net loss (752,984) 0 (689,958) (63,026) $ 0
Balance, shares at Feb. 28, 2022         33,311,887
Balance, amount at Feb. 28, 2022 (31,922,943) 11,492,630 (42,895,007) (553,878) $ 33,312
Net loss (783,441) 0 (703,825) (79,617) $ 0
Issuance of Common Shares for services, share         4,000,000
Issuance of Common Shares for services, amount 120,000 116,000     $ 4,000
Balance, shares at May. 31, 2022         37,311,887
Balance, amount at May. 31, 2022 $ (32,586,385) $ 11,608,630 $ (43,598,832) $ (633,495) $ 37,312
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
May 31, 2022
May 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (1,536,426) $ (1,255,680)
Adjustments to reconcile net loss to net cash used in operating activities:    
Issuance of Common Shares for services, amount 120,000 0
Provision for bad debts 0 2,340
Changes in operating assets and liabilities:    
Accounts receivable 11,285 (10,061)
Prepaid expenses 157,727 86,272
Inventory 146,448 111,980
Accounts payable and accrued liabilities 1,105,702 808,503
Cash provided by (used in) operating activities 4,736 (256,646)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from NCI Investment in Brain Armor 0 300,000
Cash provided by financing activities 0 300,000
NET CHANGE IN CASH AND CASH EQUIVALENTS 4,736 43,354
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 7,653 88,007
CASH AND CASH EQUIVALENTS AT END OF PERIOD 12,389 131,361
Cash paid for:    
Income taxes 0 0
Interest $ 0 $ 0
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2
ORGANIZATION AND DESCRIPTION OF BUSINESS
6 Months Ended
May 31, 2022
ORGANIZATION AND DESCRIPTION OF BUSINESS  
ORGANIZATION AND DESCRIPTION OF BUSINESS

NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Trident Brands Incorporated “we”, “our”, “the Company”) was incorporated under the laws of the State of Nevada on November 5, 2007.

 

The Company is focused on the development of high growth branded and private label consumer products and ingredients within the nutritional supplement, life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super 8-K filing at the end of August, 2014. Activities to date have focused on capital formation, organizational development and execution of its branded and private label consumer products and ingredients business plan.

XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
May 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Form 10-K filed with SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2021 as reported in the Form 10-K have been omitted.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates. The ultimate impact from COVID-19 on the Company’s operations and financial results during 2022 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, the rate at which historically large increases in unemployment rates will decrease, if at all, and whether, and the speed with which the economy recovers. We are not able to fully quantify the impact that these factors will have on our financial results during the remainder of 2022 and beyond, but expect developments related to COVID-19 to continue to materially affect the Company’s financial performance during 2022.

 

Customer Concentration

 

One customer accounted for 100.0% of total revenue for the six month period ended May 31, 2022 compared to two customers who accounted for 19.9% and 11.5% of total revenue for the six month period ended May 31, 2021. Two customers accounted for 66.5% and 33.5% of total accounts receivable as of May 31, 2022 compared to two customers for 39.4% and 29.2% as of May 31, 2021.

Fair Value of Financial Instruments

 

The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

 

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures.

 

Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

 

The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable and note payable. The fair value of the Company’s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of May 31, 2022 the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s consolidated balance sheets on a recurring basis.

 

Recent Accounting Pronouncements

 

The Company has evaluated recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that there are none that will have a material impact on the Company’s financial statements.

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.2
GOING CONCERN
6 Months Ended
May 31, 2022
GOING CONCERN  
GOING CONCERN

NOTE 3. GOING CONCERN

 

The accompanying interim consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.

 

As of May 31, 2022, the Company had $12,389 in cash and a working capital deficit of $10,286,385. The Company also has generated losses and has an accumulated deficit as of May 31, 2022. These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless Management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the next 12 months. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.2
WARRANTS AND OPTIONS
6 Months Ended
May 31, 2022
WARRANTS AND OPTIONS  
WARRANTS AND OPTIONS

NOTE 4. WARRANTS AND OPTIONS

 

The following table represents stock option activity for the six month period ended May 31, 2022:

 

 

 

Number of

Options

 

 

Weighted Average Exercise Price

 

 

Contractual

Life in Years

 

 

 Intrinsic

Value

 

Outstanding - November 30, 2021

 

 

1,532,500

 

 

$0.40

 

 

 

1.02

 

 

 

 

Exercisable - November 30, 2021

 

 

1,532,500

 

 

$0.40

 

 

 

1.02

 

 

$-0-

 

Granted

 

 

-0-

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised or Vested

 

 

-0-

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited or Expired

 

 

300,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding - May 31, 2022

 

 

1,232,500

 

 

$0.40

 

 

 

.52

 

 

 

 

 

Exercisable - May 31, 2022

 

 

1,232,500

 

 

$0.40

 

 

 

.52

 

 

$-0-

 

 

As of May 31, 2022, the Company has no outstanding warrants. All the outstanding warrants have expired.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.2
RELATED PARTY TRANSACTIONS
6 Months Ended
May 31, 2022
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS

NOTE 5. RELATED PARTY TRANSACTIONS

 

On October 15, 2021, a Promissory Note was issued to Anthony Pallante, Chairman and a significant stockholder of the Company. The Note is unsecured and was issued in consideration for payments made by Mr. Pallante on behalf of the Company to creditors in satisfaction of Company obligations. Mr. Pallante loaned the Company $20,101. The Note bears Interest at a rate of 8% per annum. All unpaid principal and accrued interest shall be due and payable upon demand by the Holder at any time subsequent to six (6) months from the date the notes were issued. As of May 31, 2022, Mr. Pallante made additional payments of $37,036 for a total of $57,137.

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.2
CONVERTIBLE DEBT
6 Months Ended
May 31, 2022
CONVERTIBLE DEBT  
CONVERTIBLE DEBT

NOTE 6. CONVERTIBLE DEBT

 

On January 29, 2015, the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2,300,000 of senior secured convertible debentures, convertible into shares of the Company’s common stock.

 

The Company received $1,800,000 of the funds from the transaction on February 5, 2015. The balance of $500,000 was received on May 14, 2015. These convertible notes were subsequently acquired by Fengate Trident, LP (‘Fengate”) on April 28, 2017.

 

The convertible debentures are convertible into shares of the Company’s common stock at an initial conversion price of $0.71 per share, for an aggregate of up to 3,239,437 shares. The debentures originally accrued interest at 6% per annum. On September 26, 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer, sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30, 2019. We considered ASC Topic 470-50, Debt Modifications and Extinguishments, and determined that the modification was not deemed substantial.

 

Due to the note being convertible to common shares of the Company, a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647,888 which was recognized as debt discount. As of November 30, 2017, the full amount of the debt discount has been amortized.

 

On September 26, 2016, the Company entered into a securities purchase agreement with a non-US institutional investor, pursuant to which, in consideration for proceeds of $4,100,000, the Company issued a secured convertible promissory note in the amount of $4,100,000. Pursuant to the securities purchase agreement, the investor has agreed, from time to time after January 1, 2017, to make additional investments at the Company’s request of up to $5,900,000. On May 9, 2017, the Company received the second tranche of funding with proceeds of $4,400,000 and on May 16, 2018 the third tranche of $1,500,000 for a total investment by the investor of $10,000,000.

 

The Company used the proceeds of the secured convertible note for general working capital purposes including settlement of accounts payable and repayment of mature loans.

In consideration of each advance made by the investor pursuant to the securities purchase agreement, the Company issued to the investor a convertible promissory note of equal value, maturing on September 30, 2019, and bearing interest at the rate of 8% per annum. Each note was secured in first priority against the present and after acquired assets of the Company and was convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price of $0.60 per share, for an aggregate of up to 16,666,667 shares. These convertible notes were subsequently acquired by Fengate on April 28, 2017.

 

Due to the notes being convertible to common shares of the Company, a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature of the notes amounted to $3,333,334 and was recognized as a debt discount. As of November 30, 2021, $3,333,334 of the debt discount was amortized to interest of which $334,988 was amortized during the current year compared to $855,987 in the prior year. As of November 30, 2021, the debt discount was fully amortized.

 

On November 30, 2018 the Company and Fengate entered into a Securities Purchase Amendment Agreement ("SPS") pursuant to which the Company has agreed to issue to Fengate additional convertible promissory notes (collectively, the “2018 and 2019 Convertible Notes”) of up to $10,000,000, subject to certain terms and conditions. Each portion of the principal amount advanced pursuant to the SPA boar interest at the rate of twelve percent (12%) per annum and will be payable monthly in arrears to Fengate. Outstanding principal and interest will continue to be secured by the general security agreement dated September 26, 2016, which forms a part of the Agreement. The holder of the note may also elect from time to time to convert all or a portion of the outstanding principal and interest into common shares of the Company at a 25% discount to the average closing price of the common shares during the 10 trading days immediately prior to the applicable conversion date. The 2018 and 2019 Convertible Notes (aka “Amended SPA Notes”) were extended until December 1, 2021. The Maturity Date of the Amended SPA Notes was extended to November 30, 2025, as described below.

       

On November 30, 2018 the Company received the first tranche of funding with proceeds of $3,400,780. The 2nd tranche of $2,804,187 was received on April 13, 2019. The 3rd tranche of $3,795,033 less $936,168 withheld for interest payments up to and including June 30, 2020 was received on November 6, 2019. On March 5, 2020, the 2018 and 2019 Convertible Notes were amended to increase the amount of the 3rd tranche by $936,168 representing the amount previously withheld as interest payment. The withheld interest was subsequently received on March 12, 2020.

 

The Company analyzed the embedded conversion option on the convertible notes for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option on the 2018 Convertible Note qualified for derivative accounting. The Company used the Black-Scholes model to value the embedded conversion option at $892,000 on the issuance date of November 30, 2018, $1,911,256 on the issuance date of April 13, 2019 and $1,696,933 on the issuance date of November 6, 2019. The assumptions used were a discount rate of 2.80%, 1.96% and 1.96%; volatility rate of 79.57%, 104.70% and 107.3%; and a term of 1.50, 1.13 and 0.57 years respectively. The fair values of the embedded conversion options were recorded as debt discount and were amortized over the term of the 2018 and 2019 Convertible Notes. Amortization of debt discount for the years ended November 30, 2021 and 2020 was $1,885,587 and $1,857,295, respectively. The unamortized discount as of November 30, 2021 is $0.

 

On January 9, 2020 the Company and Fengate entered into an Amendment to Convertible Promissory Notes Agreement to amend the terms of the convertible notes issued on February 5, 2015 (US$1,800,000), May 14, 2015 (US$500,000), September 26, 2016 (US$4,100,000), May 9, 2017 (US$4,400,000) and May 16, 2018 (US$1,500,000) (collectively the “2016 Convertible Notes”). Pursuant to the Amendment, Fengate has agreed to convert all of the 2016 Notes on or before the earlier to occur of (i) the maturity date of the 2016 Convertible Notes and (ii) the Company raising new equity investment of not less than US$2,000,000, on terms mutually acceptable to Fengate and the Company (subject to Fengate’s regulatory considerations). Conversion of the 2016 Notes will occur in a single conversion transaction at a price that is equal to a 25% discount to the average closing price of the Company’s common stock for the 10 trading days immediately prior to the conversion date, with the exact structure of the conversion to be determined by the parties. On June 3, 2020 the maturity date was extended from May 31 to December 31, 2020. The Amendment also extended the maturity date of the 2018 and 2019 Convertible Notes to December 1, 2021.

 

The Company analyzed the embedded conversion option on the amended “2016 Convertible Notes” for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option qualified for derivative accounting. On January 9, 2020 the Company used the Black-Scholes model to value the embedded conversion options at $7,965,083. The assumptions used were a discount rate of 1.96%, volatility rate of 148.8%; and a term of 0.39 years respectively. The modification resulted in $3,981,221 of APIC previously recorded for beneficial conversion feature of these convertible notes being reclassified as derivative liability.

 

On November 30, 2020, the Company entered into a fourth amendment of the 2016 Convertible Notes and the 2018 and 2019 Convertible Notes wherein the Company will issue to Fengate 29,432,320 shares of Company Preferred Stock (representing $17,659,392 of principal and interest converted into Preferred Stock at the rate of $0.60 per share), in full and complete satisfaction of (i) all amounts owing under the 2016 Convertible Notes through November 30, 2021 (including accrued interest thereon) and (ii) all accrued interest on the 2018 and 2019 Convertible Notes through November 30, 2021. The conversion was originally expected to occur by the end of June, 2021. The 2018 and 2019 Convertible Notes were further amended to (i) eliminate the conversion feature of such notes, (ii) provide for a simple interest rate of 8% per annum, with the first 2 years of interest payable at maturity of the 2018 and 2019 Convertible Notes and the last three years of interest payable quarterly beginning February 28, 2023; and (iii) extend the maturity of such notes until November 30, 2025. Pursuant to this amendment, all notes no longer qualified for derivative accounting. As such, the value of the embedded conversion options of all notes of $5,494,363 was credited to additional paid in capital.

 

The consummation of the foregoing transaction is subject to (i) authorization and issuance of the Preferred Stock, which is subject to approval of the requisite number of common shares of the Company, in accordance with Nevada law and the Company’s organizational documents, and (ii) Note Holder’s obligation to remain in compliance with regulations governing its ownership of voting shares.

The Company and Note Holder had previously undertaken to consummate the foregoing transactions no later than June 30, 2021. On March 29, 2022, the Board of Directors approved an amendment to our Certificate of Incorporation which authorizes 29,432,320 shares of Company Preferred Stock. On March 30, 2022, more than a majority in interest of our common shares by written consent approved such amendment to our Certificate of Incorporation. The effectiveness of this shareholder approval is pending the filing of an information statement with the SEC and mailing to our shareholders. The Company expects to consummate this transaction prior to September 30, 2022

 

We considered ASC Topic 470-50, Debt Modifications and Extinguishments in connection with the amendment of the interest rate and maturity date of the 2018 and 2019 Convertible Notes and determined that the modification would be considered a debt extinguishment. The unamortized discount of $1,092,295 at the date of amendment was recognized as a loss on debt extinguishment for the year ended November 30, 2020

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.2
NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC
6 Months Ended
May 31, 2022
NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC  
NON-CONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR, INC.

NOTE 7. NON-CONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR, INC.

 

On March 30, 2021, a non-US investor subscribed to the acquisition of 333,333 units of the Company’s Brain Armor Inc subsidiary. Each unit is comprised of one share of Brain Armor stock, $0.001 par value and a common stock purchase warrant evidencing the right to purchase one share of Common Stock. The 333,333 units were sold at a per unit price of USD $0.30 for an aggregate purchase price of USD $100,000 which was received by the Company on March 30, 2021. The vesting and exercise prices of the warrants are as follows:

 

 

1/3 of shares shall be exercisable 6 months after the subscription date at an exercise price of $0.45 per share

 

1/3 of shares shall be exercisable 12 months after the subscription date at an exercise price of $0.60 per share

 

1/3 of shares shall be exercisable 18 months after the subscription date at an exercise price of $0.75 per share

 

On May 5, 2021, a US investor subscribed to the acquisition of 3,333,333 units of the Company’s Brain Armor Inc subsidiary, with each unit being comprised of one share of Brain Armor stock, $0.001 par value and a common stock purchase warrant evidencing the right to purchase one share of Common Stock at a per unit price of USD $0.30 for an aggregate purchase price of USD $1,000,000 of which $100,000 was received by the Company on May 13, 2021 and $100,000 on May 27, 2021. This subscription agreement has since been terminated by mutual agreement of Brain Armor Inc. and the investor.

 

The vesting and exercise prices of the warrants are as follows:

 

 

1/3 of shares shall be exercisable 6 months after the subscription date at an exercise price of $0.45 per share

 

1/3 of shares shall be exercisable 12 months after the subscription date at an exercise price of $0.60 per share

 

1/3 of shares shall be exercisable 18 months after the subscription date at an exercise price of $0.75 per share

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
May 31, 2022
COMMITMENTS AND CONTINGENCIES  
COMMITMENTS AND CONTINGENCIES

NOTE 8. COMMITMENTS AND CONTINGENCIES

 

Everlast License Agreement

 

On December 23, 2013, the Company entered into a Deed of Assignment Agreement with Everlast World’s Boxing Headquarters Corporation, International Brand Management Limited, Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast, International Brand, Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition, a New York corporation, has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement, Sports Nutrition Products Incorporated, a wholly owned subsidiary of Trident Brands Incorporated, assigned all of its rights, title, interest and benefit to the trade mark license to the Company effective December 23, 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary, Sports Nutrition Products Inc.

 

The Everlast License Agreement includes a clause stating that Manchester Capital Incorporated will guarantee that the Licensee shall perform all of its obligations and duties under the License Agreement. If the Licensee defaults in the payment when due of any amount it is obliged to pay to Licensor under the License Agreement, or arising from its termination, Manchester Capital is unconditionally responsible to pay that amount to Licensor in the manner prescribed in the License Agreement as if it were the Licensee.

 

The Royalty Calculation, as per the terms of the agreement, are as follows: In 2013, 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014, 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015, 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards, 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed Royalty is $120,000 in 2014, $235,000 in 2015, $320,000 in 2016, $345,000 in 2017 and in 2018 onwards, if the Agreement remains in force, will be 75% of the previous Year’s Royalty Calculation or the previous Year’s Annual Minimum Guaranteed Royalty plus 10%, whichever is greater. 

 

The agreement was terminated on December 31, 2017. On January 17, 2019, Everlast World’s Boxing Headquarters Corp. (“Everlast”) filed a counter claim against the Company and other defendants. In that lawsuit, Everlast seeks payment from the defendants under a License Agreement dated June 4, 2013, for $425,555 in unpaid royalties allegedly due and owing under the License Agreement and interest on the allegedly unpaid royalties of $96,265, which interest allegedly continues to accrue. Everlast has also sought all costs, expenses, and legal fees incurred by Everlast in collecting monies that it claims are due under the License Agreement. On February 26, 2020, the court in the Everlast matter issued an Opinion and Order granting a motion to dismiss all of the Company’s claims against Everlast and granting a motion for judgment on the pleadings as to liability against the Company. The Court left open the question of damages to be awarded to Everlast. The Company had requested that the parties participate in settlement discussions before a magistrate judge or, in the alternative, that Everlast engage in limited discovery on these matters. No settlement was reached. On October 15, 2020, the Court in the Everlast case ordered, adjudged and decreed that Plaintiff Everlast have judgment and recover a total of $738,946 from the Company as follows:

 

1. $425,000 representing royalty payments due to Everlast;

2. Interest on royalty payments computed through October 15, 2020, in the sum of $242,920;

3. Costs and attorneys’ fees in the sum of $71,026

  

On November 17, 2021, The Company entered Into a Stipulation (“Stipulation”) of the litigation captioned Everlast World’s Boxing Headquarters Corp. (“Everlast”) , Plaintiff vs. Trident Brands, Inc. and Manchester Capital Inc., Defendants, Waukesha County Court Case No. 21 TJ 90.  Under the terms of the Stipulation, the Company agreed to pay Everlast on or before February 15, 2022, the sum of $650,000 in full satisfaction of the Everlast’s judgment against the Company in the amount of $738,946. Under the Stipulation, except for the first $250,000 of capital raised, the Company is required to pay Everlast 20% of the gross amount of any capital raising transaction, until the full $650,000 is paid, provided however that the full $650,000 was required to have been paid no later than February 15, 2022.   

 

The Company failed to pay Everlast the full $650,000 by February 15, 2022, as a result of which the Company is obligated to pay Everlast the judgment amount of $738,945, plus applicable interest (a total of $750,713 as of August 21, 2021) and attorney’s fees, less any payments made. The estimated liability as of May 31, 2022 due to accrued interest is $908,799 which the Company has fully accrued. The Company is currently in litigation with Everlast regarding Everlast's methods to collect the judgements.

 

Banc of America Leasing and Capital 

 

On December 1, 2020, Bank of America Leasing and Capital, LLC filed a legal action against the Company in the Superior Court for the State of California, County of San Mateo (Case NO. 20-CIV-05306), alleging breach of contract. The claim arises out of a software services contract between the Company and Oracle Corporation. Bank of America Leasing and Capital, LLC acquired Oracle’s rights under the agreement. The plaintiff claims the Company is liable for damages in the amount of $217,000 plus interests and costs. The Company has not filed an answer to this complaint. On February 22, 2021, the plaintiff requested that the Court enter a default judgment against the Company. The Company intends to engage counsel and defend against this claim.

PIT Mycell

 

On June 3, 2019, the Company filed a lawsuit against PIT Mycell, LLC, William E. Peterson III, New Age Ventures, LLC, Volker Berl, and Mycell Technologies, LLC (“Mycell”) in the Superior Court in Bergen County, New Jersey, Civil Action No. BER-L-004198-19, in which the Company seeks to require the defendants to perform under and allow the enforcement of certain notes made by Mycell and acquired by the Company in September 2017. The notes are past their stated maturity date of December 31, 2016. The Company also alleges that the parties had entered into a written Settlement Agreement Letter of Intent dated March 14, 2019 (the “Settlement”), but that the defendants repudiated it shortly thereafter. The notes had been the subject of an earlier lawsuit in Virginia in state court in Fairfax County between the Company and PIT Mycell, LLC that the Settlement was intended to resolve. The Company seeks to enforce the notes and the Settlement in the New Jersey lawsuit and requests actual damages in an amount to be proven at trial, attorneys’ fees and litigation costs, specific performance requiring certain defendants to enforce obligations under the notes against Mycell, specific performance requiring the defendants to execute a final Settlement Agreement consistent with the Settlement, an order permitting foreclosure on the collateral for the notes, and declaratory relief. On January 24, 2020, the New Jersey court denied Defendant’s Motions to dismiss the case. The parties have engaged in written discovery and exchanged productions of documents. Mycell filed for bankruptcy on November 25, 2020. The bankruptcy is completed and the Company no longer has a claim on the new company that has since emerged from bankruptcy.

 

Contingencies

 

The Company may be subject to various legal proceedings and claims that arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. There is significant judgment required in both the probability determination and as to whether an exposure can be reasonably estimated. If any legal matter, that may arise, were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s would reflect any potential claim in the consolidated financial statements for that reporting period.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.2
SUBSEQUENT EVENTS
6 Months Ended
May 31, 2022
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

NOTE 9. SUBSEQUENT EVENTS

 

On March 3, 2022, the Board authorized the following executive compensation plan:

 

 

-

Upon the closing of an initial financing (greater than $2,000,000) then the CEO shall be issued 1.5% of the fully diluted common stock and the Chairman shall receive 1.0% of the fully diluted common stock;

 

 

 

 

-

Upon the uplisting of the Company to the New York Stock Exchange (NYSE) or the Nasdaq (whether by merger or operations), then the CEO shall be issued 1.5% of the fully diluted common stock and the Chairman shall receive 1.0% of the fully diluted common stock;

 

 

 

 

-

Upon the closing of an acquisition, then the CEO shall be issued a bonus equal 3% of the total enterprise value of the deal and the Chairman shall receive 2% of the total enterprise value of the deal, which may at the option of the Company be paid in cash, or stock. If the bonus is paid in stock, then the stock shall be issued at a 20% discount to the market;

 

The Company's Board of Directors also established the following compensation and bonus plan for its CEO and reserved some bonus stock in anticipation of hiring a COO and CFO:

 

Total Revenue* (in millions)

 

 

Adjusted EBITDA*

 

 

Exercise Price**

 

 

Percent of Shares

CEO ***

 

 

Percent of Shares

COO***

 

 

Percent of Shares

CFO***

 

$

1.00

 

 

 

N/A

 

 

$

0.05

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

2.00

 

 

 

N/A

 

 

$

0.125

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

4.00

 

 

 

N/A

 

 

$

0.25

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

8.00

 

 

$

80,000

 

 

$

0.50

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

12.00

 

 

$

150,000

 

 

$

0.75

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

18.00

 

 

$

225,000

 

 

$

1.00

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

30.00

 

 

$

450,000

 

 

$

1.50

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

45.00

 

 

$

675,000

 

 

$

2.50

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

75.00

 

 

$

1,312,500

 

 

$

5.00

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

 

* Until the Company achieves the $8 million revenue target, the executive will earn 100% of eligible shares upon attainment of the relevant revenue target.  Commencing with achievement of the $8 million revenue target, the executive will earn 75% of the eligible shares upon attainment of the revenue target and will earn 25% of the eligible shares upon attainment of the Adjusted EBITDA target.

** Exercise Price shall be the lower of the Exercise Price set forth above or a 20% discount to the 5-day VWAP

** Exercise Price shall not be adjusted accordingly for any stock splits, as these Exercise Prices are after giving effect to the split.

*** Percent of Shares shall be based on the number of fully diluted common shares

 

On March 3, 2022, the Board also authorized the award of 4,000,000 shares to the Company's employees. The shares will be vested immediately and issued all at once.  

 

On April 4, 2022, the Company announced that it filed an amendment to its certificate of incorporation to: (1) authorize 29,320,432 shares of Preferred Stock which it will use to satisfy approximately $17.7 Million of principal and accrued interest due under certain convertible notes, representing a conversion rate of $0.60 per share, and (2) change the name of the corporation to SOLNI Group. The amendment authorizing the Preferred Shares was approved by a majority of the Company’s shareholders and was filed with the State of Nevada on March 31, 2022. The amendments are expected to be effective by September 30, 2022.  

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
May 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of Accounting

The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Form 10-K filed with SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2021 as reported in the Form 10-K have been omitted.

Use of Estimates and Assumptions

The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates. The ultimate impact from COVID-19 on the Company’s operations and financial results during 2022 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, the rate at which historically large increases in unemployment rates will decrease, if at all, and whether, and the speed with which the economy recovers. We are not able to fully quantify the impact that these factors will have on our financial results during the remainder of 2022 and beyond, but expect developments related to COVID-19 to continue to materially affect the Company’s financial performance during 2022.

Customer Concentration

One customer accounted for 100.0% of total revenue for the six month period ended May 31, 2022 compared to two customers who accounted for 19.9% and 11.5% of total revenue for the six month period ended May 31, 2021. Two customers accounted for 66.5% and 33.5% of total accounts receivable as of May 31, 2022 compared to two customers for 39.4% and 29.2% as of May 31, 2021.

Fair Value of Financial Instruments

The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

 

Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures.

 

Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

 

Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

 

The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable and note payable. The fair value of the Company’s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of May 31, 2022 the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s consolidated balance sheets on a recurring basis.

Recent Accounting Pronouncements

The Company has evaluated recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that there are none that will have a material impact on the Company’s financial statements.

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.2
WARRANTS AND OPTIONS (Tables)
6 Months Ended
May 31, 2022
WARRANTS AND OPTIONS (Tables)  
Schedule of stock option activity

 

 

Number of

Options

 

 

Weighted Average Exercise Price

 

 

Contractual

Life in Years

 

 

 Intrinsic

Value

 

Outstanding - November 30, 2021

 

 

1,532,500

 

 

$0.40

 

 

 

1.02

 

 

 

 

Exercisable - November 30, 2021

 

 

1,532,500

 

 

$0.40

 

 

 

1.02

 

 

$-0-

 

Granted

 

 

-0-

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised or Vested

 

 

-0-

 

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited or Expired

 

 

300,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding - May 31, 2022

 

 

1,232,500

 

 

$0.40

 

 

 

.52

 

 

 

 

 

Exercisable - May 31, 2022

 

 

1,232,500

 

 

$0.40

 

 

 

.52

 

 

$-0-

 

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.2
SUBSEQUENT EVENTS (Tables)
6 Months Ended
May 31, 2022
SUBSEQUENT EVENTS  
Schedule of subsequent events

Total Revenue* (in millions)

 

 

Adjusted EBITDA*

 

 

Exercise Price**

 

 

Percent of Shares

CEO ***

 

 

Percent of Shares

COO***

 

 

Percent of Shares

CFO***

 

$

1.00

 

 

 

N/A

 

 

$

0.05

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

2.00

 

 

 

N/A

 

 

$

0.125

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

4.00

 

 

 

N/A

 

 

$

0.25

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

8.00

 

 

$

80,000

 

 

$

0.50

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

12.00

 

 

$

150,000

 

 

$

0.75

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

18.00

 

 

$

225,000

 

 

$

1.00

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

30.00

 

 

$

450,000

 

 

$

1.50

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

45.00

 

 

$

675,000

 

 

$

2.50

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

$

75.00

 

 

$

1,312,500

 

 

$

5.00

 

 

 

1.00

%

 

 

0.25

%

 

 

0.25

%

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - integer
6 Months Ended
May 31, 2022
May 31, 2021
Revenue [Member]    
Number of customers 1 2
Revenue [Member] | Customer One [Member]    
Concentration risk percentage 100.00% 19.90%
Revenue [Member] | Customer Two [Member]    
Concentration risk percentage   11.50%
Accounts Receivable [Member]    
Number of customers 2 2
Accounts Receivable [Member] | Customer One [Member]    
Concentration risk percentage 66.50% 39.40%
Accounts Receivable [Member] | Customer Two [Member]    
Concentration risk percentage 33.50% 29.20%
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.2
GOING CONCERN (Details Narrative)
May 31, 2022
USD ($)
GOING CONCERN  
Cash $ 12,389
Working capital deficit $ 10,286,385
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.2
WARRANTS AND OPTIONS (Details) - Warrants and Stock Options [Member]
6 Months Ended
May 31, 2022
USD ($)
$ / shares
shares
Options, Exercisable | Beginning Balance 1,532,500
Options, Granted 0
Options, Exercised or Vested 0
Options, Forfeited or Expired 300,000
Options, Outstanding | Beginning Balance 1,532,500
Options, Outstanding | Ending Balance 1,232,500
Weighted Average Exercise Price, Outstanding, Begnning Balance | $ / shares $ 0.40
Weighted Average Exercise Price, Exercisable | Begnning Balance | $ / shares 0.40
Weighted Average Exercise Price, Outstanding, Ending Balance | $ / shares 0.40
Weighted Average Exercise Price, Exercisable | Ending Balance | $ / shares $ 0.40
Outstanding, Contractual Life in Years | Beginning Balance 1 year 7 days
Outstanding, Contractual Life in Years | Ending Balance 6 months 7 days
Exercisable, Contractual Life in Years | Beginning Balance 1 year 7 days
Exercisable, Contractual Life in Years | Ending Balance 6 months 7 days
Exercisable Intrinsic Value | Beginning Balance | $ $ 0
Exercisable Intrinsic Value | Ending Balance | $ $ 0
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.2
RELATED PARTY TRANSACTIONS (Details Narrative) - Mr. Pallante [Member] - USD ($)
6 Months Ended
Oct. 15, 2021
May 31, 2022
Additional payment of loan   $ 37,036
Due to related party $ 20,101  
Total loan   $ 57,137
Debt instrument interest rate 8.00%  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.2
CONVERTIBLE DEBT (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
May 14, 2015
Feb. 05, 2015
Jun. 03, 2020
Jan. 09, 2020
Sep. 30, 2019
Nov. 30, 2017
Sep. 26, 2016
Jan. 29, 2015
May 31, 2022
Nov. 30, 2021
Nov. 30, 2020
Apr. 04, 2022
Jun. 30, 2021
Mar. 05, 2020
Nov. 30, 2018
APIC reclassified to derivative liability                 $ 3,981,221            
Increased tranche amount                           $ 936,168  
Embedded conversion                     $ 5,494,363        
Beneficial conversion feature           $ 647,888                  
Amortized for prior year                 855,987            
Preferred stock, shares                       29,320,432 29,432,320    
Preferred stock shares, amount                     $ 17,659,392        
Price per share                     $ 0.60        
Debt extinguisment                 1,092,295            
Extended maturity date       Dec. 01, 2021     Sep. 30, 2019                
Conversion price (in dollars per share)                       $ 0.60      
November 6, 2019 [Member] | Third Tranche [Member]                              
Proceeds from convertible debt                 3,795,033            
Interest payment                 936,168            
November 30, 2018 [Member] | First Tranche [Member]                              
Proceeds from promissory note                 3,400,780            
April 13, 2019 [Member, | Second Tranche [Member]                              
Proceeds from promissory note                 2,804,187            
Director [Member]                              
Price per share                         $ 0.001    
Preferred stock, shares authorized                     29,432,320        
Black-Scholes Model [Member]                              
Beneficial conversion feature       $ 7,965,083                      
Discount rate       1.96%                      
Volatility rate       148.80%                      
2016 Notes [Member]                              
Extended maturity date     Dec. 31, 2020                        
2016 Notes [Member] | February 5, 2015 [Member]                              
Convertible promissory notes       $ 1,800,000                      
2016 Notes [Member] | May 14, 2015 [Member]                              
Convertible promissory notes       500,000                      
2016 Notes [Member] | May 9, 2017 [Member]                              
Convertible promissory notes       4,400,000                      
2016 Notes [Member] | May 16, 2018 [Member]                              
Convertible promissory notes       1,500,000                      
2016 Notes [Member] | September 26, 2016 [Member]                              
Convertible promissory notes       $ 4,100,000                      
Conversion Option [Member] | 2018 Convertible Note [Member] | Re-value [Member]                              
Unamortized debt discount                     $ 0        
Amortization of debt                   $ 1,885,587 $ 1,857,295        
Conversion Option [Member] | 2018 Convertible Note [Member] | November 30, 2018 [Member]                              
Black scholes model conversion option                 892,000            
Conversion Option [Member] | 2018 Convertible Note [Member] | April 13, 2019 [Member,                              
Black scholes model conversion option                 $ 1,911,256            
Conversion Option [Member] | 2018 Convertible Note [Member] | Range One [Member]                              
Term                 1 year 6 months            
Volatility                 79.57%            
Discount rate                     2.80%        
Black scholes model conversion option                 $ 1,696,933            
Conversion Option [Member] | 2018 Convertible Note [Member] | Range Two [Member]                              
Term                 1 year 1 month 17 days            
Volatility                 104.70%            
Discount rate                     1.96%        
Conversion Option [Member] | 2018 Convertible Note [Member] | Range Three [Member]                              
Term                 6 months 25 days            
Volatility                 107.30%            
Discount rate                     1.96%        
Securities Purchase Agreement [Member] | 2018 Convertible Note [Member]                              
Principal amount of debt                             $ 10,000,000
Bearing interest rate                             12.00%
Convertible note description                 Company at a 25% discount to the average closing price of the common shares during the 10 trading days immediately prior to the applicable conversion date.            
Convertible Debt [Member]                              
Bearing interest rate             6.00%                
Convertible Debt [Member] | Securities Purchase Agreement [Member]                              
Proceeds from convertible debt $ 500,000 $ 1,800,000         $ 4,100,000                
Amortization of debt discount                 $ 3,333,334            
Principal amount of debt               $ 2,300,000              
Intrinsic value of notes                 3,333,334            
Common stock conversion, shares         16,666,667     3,239,437              
Bearing interest rate             8.00% 6.00%              
Interest amortized                 $ 334,988            
Proceeds from promissory note             $ 4,100,000                
Additional funding amount             5,900,000                
Aggregate amount of promissory note             $ 10,000,000                
Conversion price (in dollars per share)         $ 0.60     $ 0.71              
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.2
NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC (Details Narrative) - Brain Armor Inc [Member] - USD ($)
May 27, 2021
May 13, 2021
May 05, 2021
Mar. 30, 2021
Per unit price     $ 0.30 $ 0.30
Purchase price $ 100,000 $ 100,000 $ 1,000,000 $ 100,000
Number of shares acquired     3,333,333 333,333
Par value     $ 0.001 $ 0.001
Common stock shares purchased       333,333
Exercisable after 12 months [Member]        
One third warrant exercise price     0.60 $ 0.60
Exercisable after 18 months [Member]        
One third warrant exercise price     0.75 0.75
Subscription Arrangement [Member]        
One third warrant exercise price     $ 0.45 $ 0.45
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Oct. 15, 2020
Nov. 17, 2021
May 31, 2022
Feb. 15, 2022
Nov. 30, 2017
Nov. 30, 2016
Nov. 30, 2015
Nov. 30, 2014
Accrued interest liability     $ 908,799          
Annual Minimum Guaranteed Royalty         $ 345,000 $ 320,000 $ 235,000 $ 120,000
Description of annual minimum guaranteed royalty     and in 2018 onwards, if the Agreement remains in force, will be 75% of the previous Year’s Royalty Calculation or the previous Year’s Annual Minimum Guaranteed Royalty plus 10%, whichever is greater.          
Royalty Calculation Year 2013 [Member]                
Percentage of net retail sales     7.00%          
Percentage of direct response sales revenue     7% of 60%          
Royalty Calculation Year 2014 [Member]                
Percentage of net retail sales     8.00%          
Percentage of direct response sales revenue     8% of 60%          
Royalty Calculation Year 2015 [Member]                
Percentage of net retail sales     9.00%          
Percentage of direct response sales revenue     9% of 60%          
Royalty Calculation Year 2016 [Member]                
Percentage of net retail sales     10.00%          
Percentage of direct response sales revenue     10% of 60%          
June 4, 2013 [Member] | License Agreement [Member]                
Payment of unpaid royalties     $ 425,555          
Payment of unpaid interest     96,265          
Plantiff Everlast[Member]                
Recovery, amount $ 738,946              
Payment due 425,000              
Ineterest royalty payment 242,920              
Cost and attorney's fees $ 71,026              
Final obligation to pay after default as of Aug, 21, 2021       $ 750,713        
Plantiff Everlast[Member] | December 1, 2020 [Member]                
Cost for damages     $ 217,000          
President And CEO [Member]                
Litigation settlement, amount   $ 650,000            
Capital raised, amount   $ 250,000            
Percentage of gross amount to pay for capital raising transaction, until the full amount paid     20.00%          
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.2
SUBSEQUENT EVENTS (Details) - USD ($)
3 Months Ended 6 Months Ended
May 31, 2022
May 31, 2021
May 31, 2022
May 31, 2021
Total Revenue $ 125,280 $ 46,243 $ 125,280 $ 190,291
Exercise Price Range Five [Member]        
Percent of Shares CEO     1.00%  
Total Revenue     $ 120,000.00  
Exercise Price     $ 0.75  
Percent of Shares COO     0.25%  
Percent of Shares CFO     0.25%  
Adjusted EBITDA     $ 150,000  
Exercise Price Range Seven [Member]        
Percent of Shares CEO     1.00%  
Total Revenue     $ 300,000.00  
Exercise Price     $ 1.50  
Percent of Shares COO     0.25%  
Percent of Shares CFO     0.25%  
Adjusted EBITDA     $ 450,000  
Exercise Price Range Six [Member]        
Percent of Shares CEO     1.00%  
Total Revenue     $ 180,000.00  
Exercise Price     $ 1.00  
Percent of Shares COO     0.25%  
Percent of Shares CFO     0.25%  
Adjusted EBITDA     $ 225,000  
Exercise Price Range Four [Member]        
Percent of Shares CEO     1.00%  
Total Revenue     $ 80,000.00  
Exercise Price     $ 0.50  
Percent of Shares COO     0.25%  
Percent of Shares CFO     0.25%  
Adjusted EBITDA     $ 80,000  
Exercise Prices Range Three [Member]        
Percent of Shares CEO     1.00%  
Total Revenue     $ 40,000.00  
Exercise Price     $ 0.25  
Percent of Shares COO     0.25%  
Percent of Shares CFO     0.25%  
Exercis Price Range Eight [Member]        
Percent of Shares CEO     1.00%  
Total Revenue     $ 450,000.00  
Exercise Price     $ 2.50  
Percent of Shares COO     0.25%  
Percent of Shares CFO     0.25%  
Adjusted EBITDA     $ 675,000  
Exercises Price Range Nine [Member]        
Percent of Shares CEO     1.00%  
Total Revenue     $ 750,000.00  
Exercise Price     $ 5.00  
Percent of Shares COO     0.25%  
Percent of Shares CFO     0.25%  
Adjusted EBITDA     $ 1,312,500  
Exercise Price Range One [Member]        
Percent of Shares CEO     1.00%  
Total Revenue     $ 10,000.00  
Exercise Price     $ 0.05  
Percent of Shares COO     0.25%  
Percent of Shares CFO     0.25%  
Exercise Price Range Two [Member]        
Percent of Shares CEO     1.00%  
Total Revenue     $ 20,000.00  
Exercise Price     $ 0.125  
Percent of Shares COO     0.25%  
Percent of Shares CFO     0.25%  
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
$ / shares in Units, $ in Millions
Mar. 03, 2022
Apr. 04, 2022
Jun. 30, 2021
SUBSEQUENT EVENTS      
Preferred stock, shares   29,320,432 29,432,320
Principal and accrued interest   $ 17.7  
Conversion price (in dollars per share)   $ 0.60  
Subsequent description Upon the closing of an initial financing (greater than $2,000,000) then the CEO shall be issued 1.5% of the fully diluted common stock and the Chairman shall receive 1.0% of the fully diluted common stock    
Authorized shares to employees 4,000,000    
XML 39 tdnt_10q_htm.xml IDEA: XBRL DOCUMENT 0001421907 2021-12-01 2022-05-31 0001421907 2022-03-01 2022-03-03 0001421907 2022-04-04 0001421907 tdnt:ExercisPriceRangeNineMember 2021-12-01 2022-05-31 0001421907 tdnt:ExercisePriceRangeSevenMember 2021-12-01 2022-05-31 0001421907 tdnt:ExercisePriceRangeSixMember 2021-12-01 2022-05-31 0001421907 tdnt:ExercisePriceRangeFiveMember 2021-12-01 2022-05-31 0001421907 tdnt:ExercisePricesRangeFourMember 2021-12-01 2022-05-31 0001421907 tdnt:ExercisePricesRangeThreeMember 2021-12-01 2022-05-31 0001421907 tdnt:ExercisePriceRangeTwoMember 2021-12-01 2022-05-31 0001421907 tdnt:ExercisePriceRangeOneMember 2021-12-01 2022-05-31 0001421907 tdnt:ExercisPriceRangeEightMember 2021-12-01 2022-05-31 0001421907 tdnt:JuneFourTwentyThirteenMember us-gaap:LicenseAgreementTermsMember 2021-12-01 2022-05-31 0001421907 tdnt:RoyaltyCalculationYearTwoThousandSixteenMember 2021-12-01 2022-05-31 0001421907 tdnt:RoyaltyCalculationYearFifteenMember 2021-12-01 2022-05-31 0001421907 tdnt:RoyaltyCalculationYear2014Member 2021-12-01 2022-05-31 0001421907 tdnt:RoyaltyCalculationYear2013Member 2021-12-01 2022-05-31 0001421907 tdnt:PlantiffEverlastMember tdnt:DecemberOneTwentyTwentyMember 2021-12-01 2022-05-31 0001421907 tdnt:PlantiffEverlastMember 2022-02-15 0001421907 tdnt:PlantiffEverlastMember 2020-10-01 2020-10-15 0001421907 srt:ChiefExecutiveOfficerMember 2021-12-01 2022-05-31 0001421907 srt:ChiefExecutiveOfficerMember 2021-11-17 0001421907 srt:ChiefExecutiveOfficerMember 2021-11-01 2021-11-17 0001421907 2015-11-30 0001421907 2016-11-30 0001421907 2017-11-30 0001421907 2014-11-30 0001421907 srt:SubsidiariesMember tdnt:SubscriptionArrangementTwoMember 2021-05-05 0001421907 srt:SubsidiariesMember tdnt:SubscriptionArrangementOneMember 2021-05-05 0001421907 srt:SubsidiariesMember us-gaap:SubscriptionArrangementMember 2021-05-05 0001421907 srt:SubsidiariesMember tdnt:SubscriptionArrangementTwoMember 2021-03-30 0001421907 srt:SubsidiariesMember tdnt:SubscriptionArrangementOneMember 2021-03-30 0001421907 srt:SubsidiariesMember us-gaap:SubscriptionArrangementMember 2021-03-30 0001421907 tdnt:BrainArmorIncMember 2021-05-27 0001421907 tdnt:BrainArmorIncMember 2021-05-13 0001421907 tdnt:BrainArmorIncMember 2021-05-05 0001421907 tdnt:BrainArmorIncMember 2021-03-30 0001421907 tdnt:SeptemberTwoSixTwentySixteenMember tdnt:TwentySixteenNotesMember 2020-01-09 0001421907 tdnt:MaySixteenTwentyEighteenMember tdnt:TwentySixteenNotesMember 2020-01-09 0001421907 tdnt:MayNineTwentySeventeenMember tdnt:TwentySixteenNotesMember 2020-01-09 0001421907 tdnt:MayFourteenTwentyFifteenMember tdnt:TwentySixteenNotesMember 2020-01-09 0001421907 tdnt:FebruaryFiveTwentyFifteenMember tdnt:TwentySixteenNotesMember 2020-01-09 0001421907 tdnt:April132019Member tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember 2021-12-01 2022-05-31 0001421907 tdnt:November302018Member tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember 2021-12-01 2022-05-31 0001421907 tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember tdnt:RangeThreeMember 2020-11-30 0001421907 tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember tdnt:RangeTwoMember 2020-11-30 0001421907 tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember tdnt:RangeOneMember 2020-11-30 0001421907 tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember tdnt:RangeThreeMember 2021-12-01 2022-05-31 0001421907 tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember tdnt:RangeTwoMember 2021-12-01 2022-05-31 0001421907 tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember tdnt:RangeOneMember 2021-12-01 2022-05-31 0001421907 tdnt:RevalueMember tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember 2019-12-01 2020-11-30 0001421907 tdnt:RevalueMember tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember 2020-12-01 2021-11-30 0001421907 tdnt:RevalueMember tdnt:ConversionOptionMember tdnt:TwoThousandEighteenConvertibleNoteMember 2020-11-30 0001421907 tdnt:SecuritiesPurchaseAgreementMember tdnt:TwoThousandEighteenConvertibleNoteMember 2021-12-01 2022-05-31 0001421907 tdnt:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2019-09-30 0001421907 tdnt:April132019Member tdnt:SecondTrancheMember 2021-12-01 2022-05-31 0001421907 tdnt:November302018Member tdnt:FirstTrancheMember 2021-12-01 2022-05-31 0001421907 tdnt:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2016-09-26 0001421907 us-gaap:ConvertibleDebtMember 2016-09-26 0001421907 tdnt:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2019-09-01 2019-09-30 0001421907 tdnt:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2015-01-01 2015-01-29 0001421907 tdnt:SecuritiesPurchaseAgreementMember tdnt:TwoThousandEighteenConvertibleNoteMember 2018-11-30 0001421907 tdnt:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2015-01-29 0001421907 tdnt:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2021-12-01 2022-05-31 0001421907 tdnt:NovemberSixTwentyNinteenMember tdnt:ThirdTrancheMember 2021-12-01 2022-05-31 0001421907 tdnt:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2015-02-01 2015-02-05 0001421907 tdnt:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2015-05-01 2015-05-14 0001421907 tdnt:SecuritiesPurchaseAgreementMember us-gaap:ConvertibleDebtMember 2016-09-01 2016-09-26 0001421907 srt:DirectorMember 2020-11-30 0001421907 2019-12-08 2020-01-09 0001421907 2016-09-01 2016-09-26 0001421907 tdnt:TwentySixteenNotesMember 2020-05-15 2020-06-03 0001421907 srt:DirectorMember 2021-06-30 0001421907 2021-06-30 0001421907 tdnt:BlackScholesModelMember 2019-12-08 2020-01-09 0001421907 2017-11-01 2017-11-30 0001421907 2020-03-05 0001421907 tdnt:MrPallanteMember 2021-10-01 2021-10-15 0001421907 tdnt:MrPallanteMember 2022-05-31 0001421907 tdnt:MrPallanteMember 2021-10-15 0001421907 tdnt:MrPallanteMember 2021-12-01 2022-05-31 0001421907 tdnt:StockOptionsMember 2022-05-31 0001421907 tdnt:StockOptionsMember 2021-12-01 2022-05-31 0001421907 tdnt:StockOptionsMember 2021-11-30 0001421907 tdnt:CustomerTwoMember us-gaap:AccountsReceivableMember 2021-12-01 2022-05-31 0001421907 tdnt:CustomerTwoMember us-gaap:AccountsReceivableMember 2020-12-01 2021-05-31 0001421907 tdnt:CustomerOneMember us-gaap:AccountsReceivableMember 2020-12-01 2021-05-31 0001421907 tdnt:CustomerOneMember us-gaap:AccountsReceivableMember 2021-12-01 2022-05-31 0001421907 tdnt:CustomerTwoMember tdnt:RevenueMember 2020-12-01 2021-05-31 0001421907 tdnt:CustomerOneMember tdnt:RevenueMember 2020-12-01 2021-05-31 0001421907 tdnt:CustomerOneMember tdnt:RevenueMember 2021-12-01 2022-05-31 0001421907 us-gaap:AccountsReceivableMember 2020-12-01 2021-05-31 0001421907 us-gaap:AccountsReceivableMember 2021-12-01 2022-05-31 0001421907 tdnt:RevenueMember 2020-12-01 2021-05-31 0001421907 tdnt:RevenueMember 2021-12-01 2022-05-31 0001421907 us-gaap:NoncontrollingInterestMember 2022-05-31 0001421907 us-gaap:RetainedEarningsMember 2022-05-31 0001421907 us-gaap:AdditionalPaidInCapitalMember 2022-05-31 0001421907 us-gaap:CommonStockMember 2022-05-31 0001421907 us-gaap:NoncontrollingInterestMember 2022-03-01 2022-05-31 0001421907 us-gaap:RetainedEarningsMember 2022-03-01 2022-05-31 0001421907 us-gaap:AdditionalPaidInCapitalMember 2022-03-01 2022-05-31 0001421907 us-gaap:CommonStockMember 2022-03-01 2022-05-31 0001421907 2022-02-28 0001421907 us-gaap:NoncontrollingInterestMember 2022-02-28 0001421907 us-gaap:RetainedEarningsMember 2022-02-28 0001421907 us-gaap:AdditionalPaidInCapitalMember 2022-02-28 0001421907 us-gaap:CommonStockMember 2022-02-28 0001421907 2021-12-01 2022-02-28 0001421907 us-gaap:NoncontrollingInterestMember 2021-12-01 2022-02-28 0001421907 us-gaap:RetainedEarningsMember 2021-12-01 2022-02-28 0001421907 us-gaap:AdditionalPaidInCapitalMember 2021-12-01 2022-02-28 0001421907 us-gaap:CommonStockMember 2021-12-01 2022-02-28 0001421907 us-gaap:NoncontrollingInterestMember 2021-11-30 0001421907 us-gaap:RetainedEarningsMember 2021-11-30 0001421907 us-gaap:AdditionalPaidInCapitalMember 2021-11-30 0001421907 us-gaap:CommonStockMember 2021-11-30 0001421907 2021-05-31 0001421907 us-gaap:NoncontrollingInterestMember 2021-05-31 0001421907 us-gaap:RetainedEarningsMember 2021-05-31 0001421907 us-gaap:AdditionalPaidInCapitalMember 2021-05-31 0001421907 us-gaap:CommonStockMember 2021-05-31 0001421907 us-gaap:NoncontrollingInterestMember 2021-03-01 2021-05-31 0001421907 us-gaap:RetainedEarningsMember 2021-03-01 2021-05-31 0001421907 us-gaap:AdditionalPaidInCapitalMember 2021-03-01 2021-05-31 0001421907 us-gaap:CommonStockMember 2021-03-01 2021-05-31 0001421907 2021-02-28 0001421907 us-gaap:NoncontrollingInterestMember 2021-02-28 0001421907 us-gaap:RetainedEarningsMember 2021-02-28 0001421907 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0001421907 us-gaap:CommonStockMember 2021-02-28 0001421907 2020-12-01 2021-02-28 0001421907 us-gaap:NoncontrollingInterestMember 2020-12-01 2021-02-28 0001421907 us-gaap:RetainedEarningsMember 2020-12-01 2021-02-28 0001421907 us-gaap:AdditionalPaidInCapitalMember 2020-12-01 2021-02-28 0001421907 us-gaap:CommonStockMember 2020-12-01 2021-02-28 0001421907 2020-11-30 0001421907 us-gaap:NoncontrollingInterestMember 2020-11-30 0001421907 us-gaap:RetainedEarningsMember 2020-11-30 0001421907 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0001421907 us-gaap:CommonStockMember 2020-11-30 0001421907 2020-12-01 2021-05-31 0001421907 2021-03-01 2021-05-31 0001421907 2022-03-01 2022-05-31 0001421907 2021-11-30 0001421907 2022-05-31 0001421907 2022-07-27 iso4217:USD shares iso4217:USD shares tdnt:integer pure 0001421907 false --11-30 Q2 2022 false 0.001 300000000 33311887 37311887 1 2 2 2 0.001 29432320 650000 10-Q true 2022-05-31 000-53707 TRIDENT BRANDS INCORPORATED NV 433 Plaza Real Suite 275 Boca Raton FL 33432 561 962-4122 Yes Yes Non-accelerated Filer true true false false 37311887 12389 7653 11286 160210 1073 12358 401606 401606 735476 881924 419 158146 749357 1060081 749357 1060081 549941 524207 10485801 9405833 11035742 9930040 0 0 22300000 22300000 33335742 32230040 0.001 300000000 37311887 33311887 37312 32312 11608630 11492630 -633495 -490852 -43598832 -42205049 -32586385 -31169959 749357 1060081 125280 46243 125280 190291 146448 24580 146448 103368 -21168 21663 -21168 86923 528103 537978 945412 942262 -549271 -516315 -966580 -855339 234171 200008 569846 400341 -234171 -200008 -569846 -400341 -783442 -716323 -1536426 -1255680 -703825 -646092 -1393783 -1181590 -79617 -70231 -142643 -74090 -0.02 -0.02 -0.04 -0.04 37181452 32311887 35267931 32311887 32311887 32312 11458630 -39522278 -387147 -28418483 0 0 -535498 -3859 -539357 32311887 32312 11458630 -40057776 -391006 -28957840 300000 300000 0 0 -646091 -70231 -716323 32311887 32312 11458630 -40703867 -161237 -29374162 33311887 33312 11492630 -42205049 -490852 -31169959 0 0 -689958 -63026 -752984 33311887 33312 11492630 -42895007 -553878 -31922943 4000000 4000 116000 120000 0 0 -703825 -79617 -783441 37311887 37312 11608630 -43598832 -633495 -32586385 -1536426 -1255680 120000 0 0 2340 11285 -10061 157727 86272 146448 111980 1105702 808503 4736 -256646 0 300000 0 300000 4736 43354 7653 88007 12389 131361 0 0 0 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Trident Brands Incorporated “we”, “our”, “the Company”) was incorporated under the laws of the State of Nevada on November 5, 2007. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company is focused on the development of high growth branded and private label consumer products and ingredients within the nutritional supplement, life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super 8-K filing at the end of August, 2014. Activities to date have focused on capital formation, organizational development and execution of its branded and private label consumer products and ingredients business plan. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Basis of Presentation</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Form 10-K filed with SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2021 as reported in the Form 10-K have been omitted.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Use of Estimates</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates. The ultimate impact from COVID-19 on the Company’s operations and financial results during 2022 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, the rate at which historically large increases in unemployment rates will decrease, if at all, and whether, and the speed with which the economy recovers. We are not able to fully quantify the impact that these factors will have on our financial results during the remainder of 2022 and beyond, but expect developments related to COVID-19 to continue to materially affect the Company’s financial performance during 2022.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Customer Concentration </span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">One customer accounted for 100.0% of total revenue for the six month period ended May 31, 2022 compared to two customers who accounted for 19.9% and 11.5% of total revenue for the six month period ended May 31, 2021. Two customers accounted for 66.5% and 33.5% of total accounts receivable as of May 31, 2022 compared to two customers for 39.4% and 29.2% as of May 31, 2021. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Fair Value of Financial Instruments</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable and note payable. The fair value of the Company’s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of May 31, 2022 the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s consolidated balance sheets on a recurring basis. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong><span style="text-decoration:underline">Recent Accounting Pronouncements</span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that there are none that will have a material impact on the Company’s financial statements.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Form 10-K filed with SEC. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements which would substantially duplicate the disclosure contained in the audited financial statements for fiscal 2021 as reported in the Form 10-K have been omitted.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. These estimates and judgments are based on historical information, information that is currently available to the Company and on various other assumptions that the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates. The ultimate impact from COVID-19 on the Company’s operations and financial results during 2022 will depend on, among other things, the ultimate severity and scope of the pandemic, the pace at which governmental and private travel restrictions and public concerns about public gatherings will ease, the rate at which historically large increases in unemployment rates will decrease, if at all, and whether, and the speed with which the economy recovers. We are not able to fully quantify the impact that these factors will have on our financial results during the remainder of 2022 and beyond, but expect developments related to COVID-19 to continue to materially affect the Company’s financial performance during 2022.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">One customer accounted for 100.0% of total revenue for the six month period ended May 31, 2022 compared to two customers who accounted for 19.9% and 11.5% of total revenue for the six month period ended May 31, 2021. Two customers accounted for 66.5% and 33.5% of total accounts receivable as of May 31, 2022 compared to two customers for 39.4% and 29.2% as of May 31, 2021. </p> 1 0.199 0.115 0.665 0.335 0.394 0.292 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, “Fair Value Measurements and Disclosures”. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 33.75pt; text-align:justify;">Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable and note payable. The fair value of the Company’s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of May 31, 2022 the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s consolidated balance sheets on a recurring basis. </p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has evaluated recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that there are none that will have a material impact on the Company’s financial statements.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 3. GOING CONCERN </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying interim consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of May 31, 2022, the Company had $12,389 in cash and a working capital deficit of $10,286,385. The Company also has generated losses and has an accumulated deficit as of May 31, 2022. These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless Management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the next 12 months. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> 12389 10286385 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 4. WARRANTS AND OPTIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The following table represents stock option activity for the six month period ended May 31, 2022:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life in Years</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> <strong>Intrinsic </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding - November 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,532,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exercisable - November 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,532,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-0-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-0-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exercised or Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-0-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forfeited or Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">300,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Outstanding - May 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,232,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">.52</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exercisable - May 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,232,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">.52</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-0-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of May 31, 2022, the Company has no outstanding warrants. All the outstanding warrants have expired. </p> <table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Number of </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Options</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Weighted Average Exercise Price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Contractual </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Life in Years</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> <strong>Intrinsic </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Value</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Outstanding - November 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,532,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exercisable - November 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,532,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.02</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-0-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-0-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exercised or Vested</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-0-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forfeited or Expired</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">300,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Outstanding - May 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,232,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">.52</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Exercisable - May 31, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,232,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">.52</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-0-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> 1532500 0.40 P1Y7D 1532500 0.40 P1Y7D 0 0 0 300000 1232500 0.40 P0Y6M7D 0.40 P0Y6M7D 0 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 5. RELATED PARTY TRANSACTIONS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On October 15, 2021, a Promissory Note was issued to Anthony Pallante, Chairman and a significant stockholder of the Company. The Note is unsecured and was issued in consideration for payments made by Mr. Pallante on behalf of the Company to creditors in satisfaction of Company obligations. Mr. Pallante loaned the Company $20,101. The Note bears Interest at a rate of 8% per annum. All unpaid principal and accrued interest shall be due and payable upon demand by the Holder at any time subsequent to six (6) months from the date the notes were issued. As of May 31, 2022, Mr. Pallante made additional payments of $37,036 for a total of $57,137. </p> 20101 0.08 37036 57137 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 6. CONVERTIBLE DEBT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 29, 2015, the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2,300,000 of senior secured convertible debentures, convertible into shares of the Company’s common stock.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company received $1,800,000 of the funds from the transaction on February 5, 2015. The balance of $500,000 was received on May 14, 2015. These convertible notes were subsequently acquired by Fengate Trident, LP (‘Fengate”) on April 28, 2017.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The convertible debentures are convertible into shares of the Company’s common stock at an initial conversion price of $0.71 per share, for an aggregate of up to 3,239,437 shares. The debentures originally accrued interest at 6% per annum. On September 26, 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer, sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30, 2019. We considered ASC Topic 470-50, Debt Modifications and Extinguishments, and determined that the modification was not deemed substantial.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the note being convertible to common shares of the Company, a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647,888 which was recognized as debt discount. As of November 30, 2017, the full amount of the debt discount has been amortized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On September 26, 2016, the Company entered into a securities purchase agreement with a non-US institutional investor, pursuant to which, in consideration for proceeds of $4,100,000, the Company issued a secured convertible promissory note in the amount of $4,100,000. Pursuant to the securities purchase agreement, the investor has agreed, from time to time after January 1, 2017, to make additional investments at the Company’s request of up to $5,900,000. On May 9, 2017, the Company received the second tranche of funding with proceeds of $4,400,000 and on May 16, 2018 the third tranche of $1,500,000 for a total investment by the investor of $10,000,000.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company used the proceeds of the secured convertible note for general working capital purposes including settlement of accounts payable and repayment of mature loans.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In consideration of each advance made by the investor pursuant to the securities purchase agreement, the Company issued to the investor a convertible promissory note of equal value, maturing on September 30, 2019, and bearing interest at the rate of 8% per annum. Each note was secured in first priority against the present and after acquired assets of the Company and was convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price of $0.60 per share, for an aggregate of up to 16,666,667 shares. These convertible notes were subsequently acquired by Fengate on April 28, 2017. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the notes being convertible to common shares of the Company, a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature of the notes amounted to $3,333,334 and was recognized as a debt discount. As of November 30, 2021, $3,333,334 of the debt discount was amortized to interest of which $334,988 was amortized during the current year compared to $855,987 in the prior year. As of November 30, 2021, the debt discount was fully amortized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 30, 2018 the Company and Fengate entered into a Securities Purchase Amendment Agreement ("SPS") pursuant to which the Company has agreed to issue to Fengate additional convertible promissory notes (collectively, the “2018 and 2019 Convertible Notes”) of up to $10,000,000, subject to certain terms and conditions. Each portion of the principal amount advanced pursuant to the SPA boar interest at the rate of twelve percent (12%) per annum and will be payable monthly in arrears to Fengate. Outstanding principal and interest will continue to be secured by the general security agreement dated September 26, 2016, which forms a part of the Agreement. The holder of the note may also elect from time to time to convert all or a portion of the outstanding principal and interest into common shares of the Company at a 25% discount to the average closing price of the common shares during the 10 trading days immediately prior to the applicable conversion date. The 2018 and 2019 Convertible Notes (aka “Amended SPA Notes”) were extended until December 1, 2021. The Maturity Date of the Amended SPA Notes was extended to November 30, 2025, as described below.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">       </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 30, 2018 the Company received the first tranche of funding with proceeds of $3,400,780. The 2<sup style="vertical-align:super">nd</sup> tranche of $2,804,187 was received on April 13, 2019. The 3<sup style="vertical-align:super">rd</sup> tranche of $3,795,033 less $936,168 withheld for interest payments up to and including June 30, 2020 was received on November 6, 2019. On March 5, 2020, the 2018 and 2019 Convertible Notes were amended to increase the amount of the 3rd tranche by $936,168 representing the amount previously withheld as interest payment. The withheld interest was subsequently received on March 12, 2020. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company analyzed the embedded conversion option on the convertible notes for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option on the 2018 Convertible Note qualified for derivative accounting. The Company used the Black-Scholes model to value the embedded conversion option at $892,000 on the issuance date of November 30, 2018, $1,911,256 on the issuance date of April 13, 2019 and $1,696,933 on the issuance date of November 6, 2019. The assumptions used were a discount rate of 2.80%, 1.96% and 1.96%; volatility rate of 79.57%, 104.70% and 107.3%; and a term of 1.50, 1.13 and 0.57 years respectively. The fair values of the embedded conversion options were recorded as debt discount and were amortized over the term of the 2018 and 2019 Convertible Notes. Amortization of debt discount for the years ended November 30, 2021 and 2020 was $1,885,587 and $1,857,295, respectively. The unamortized discount as of November 30, 2021 is $0.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On January 9, 2020 the Company and Fengate entered into an Amendment to Convertible Promissory Notes Agreement to amend the terms of the convertible notes issued on February 5, 2015 (US$1,800,000), May 14, 2015 (US$500,000), September 26, 2016 (US$4,100,000), May 9, 2017 (US$4,400,000) and May 16, 2018 (US$1,500,000) (collectively the “2016 Convertible Notes”). Pursuant to the Amendment, Fengate has agreed to convert all of the 2016 Notes on or before the earlier to occur of (i) the maturity date of the 2016 Convertible Notes and (ii) the Company raising new equity investment of not less than US$2,000,000, on terms mutually acceptable to Fengate and the Company (subject to Fengate’s regulatory considerations). Conversion of the 2016 Notes will occur in a single conversion transaction at a price that is equal to a 25% discount to the average closing price of the Company’s common stock for the 10 trading days immediately prior to the conversion date, with the exact structure of the conversion to be determined by the parties. On June 3, 2020 the maturity date was extended from May 31 to December 31, 2020. The Amendment also extended the maturity date of the 2018 and 2019 Convertible Notes to December 1, 2021.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company analyzed the embedded conversion option on the amended “2016 Convertible Notes” for derivative accounting consideration under ASC 815-15 “Derivatives and Hedging” and determined that the conversion option qualified for derivative accounting. On January 9, 2020 the Company used the Black-Scholes model to value the embedded conversion options at $7,965,083. The assumptions used were a discount rate of 1.96%, volatility rate of 148.8%; and a term of 0.39 years respectively. The modification resulted in $3,981,221 of APIC previously recorded for beneficial conversion feature of these convertible notes being reclassified as derivative liability.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 30, 2020, the Company entered into a fourth amendment of the 2016 Convertible Notes and the 2018 and 2019 Convertible Notes wherein the Company will issue to Fengate 29,432,320 shares of Company Preferred Stock (representing $17,659,392 of principal and interest converted into Preferred Stock at the rate of $0.60 per share), in full and complete satisfaction of (i) all amounts owing under the 2016 Convertible Notes through November 30, 2021 (including accrued interest thereon) and (ii) all accrued interest on the 2018 and 2019 Convertible Notes through November 30, 2021. The conversion was originally expected to occur by the end of June, 2021. The 2018 and 2019 Convertible Notes were further amended to (i) eliminate the conversion feature of such notes, (ii) provide for a simple interest rate of 8% per annum, with the first 2 years of interest payable at maturity of the 2018 and 2019 Convertible Notes and the last three years of interest payable quarterly beginning February 28, 2023; and (iii) extend the maturity of such notes until November 30, 2025. Pursuant to this amendment, all notes no longer qualified for derivative accounting. As such, the value of the embedded conversion options of all notes of $5,494,363 was credited to additional paid in capital. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The consummation of the foregoing transaction is subject to (i) authorization and issuance of the Preferred Stock, which is subject to approval of the requisite number of common shares of the Company, in accordance with Nevada law and the Company’s organizational documents, and (ii) Note Holder’s obligation to remain in compliance with regulations governing its ownership of voting shares. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company and Note Holder had previously undertaken to consummate the foregoing transactions no later than June 30, 2021. On March 29, 2022, the Board of Directors approved an amendment to our Certificate of Incorporation which authorizes 29,432,320 shares of Company Preferred Stock. On March 30, 2022, more than a majority in interest of our common shares by written consent approved such amendment to our Certificate of Incorporation. The effectiveness of this shareholder approval is pending the filing of an information statement with the SEC and mailing to our shareholders. The Company expects to consummate this transaction prior to September 30, 2022 </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We considered ASC Topic 470-50, Debt Modifications and Extinguishments in connection with the amendment of the interest rate and maturity date of the 2018 and 2019 Convertible Notes and determined that the modification would be considered a debt extinguishment. The unamortized discount of $1,092,295 at the date of amendment was recognized as a loss on debt extinguishment for the year ended November 30, 2020</p> 2300000 1800000 500000 0.71 3239437 0.06 0.06 2019-09-30 647888 4100000 4100000 5900000 10000000 0.60 16666667 3333334 3333334 334988 855987 10000000 0.12 Company at a 25% discount to the average closing price of the common shares during the 10 trading days immediately prior to the applicable conversion date. 3400780 2804187 3795033 936168 936168 892000 1911256 1696933 0.0280 0.0196 0.0196 0.7957 1.0470 1.073 P1Y6M P1Y1M17D P0Y6M25D 1885587 1857295 0 1800000 500000 4100000 4400000 1500000 2020-12-31 2021-12-01 7965083 0.0196 1.488 3981221 29432320 17659392 0.60 0.08 5494363 1092295 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 7. NON-CONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR, INC.</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 30, 2021, a non-US investor subscribed to the acquisition of 333,333 units of the Company’s Brain Armor Inc subsidiary. Each unit is comprised of one share of Brain Armor stock, $0.001 par value and a common stock purchase warrant evidencing the right to purchase one share of Common Stock. The 333,333 units were sold at a per unit price of USD $0.30 for an aggregate purchase price of USD $100,000 which was received by the Company on March 30, 2021. The vesting and exercise prices of the warrants are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">●</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1/3 of shares shall be exercisable 6 months after the subscription date at an exercise price of $0.45 per share</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">●</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1/3 of shares shall be exercisable 12 months after the subscription date at an exercise price of $0.60 per share</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">●</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1/3 of shares shall be exercisable 18 months after the subscription date at an exercise price of $0.75 per share</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 5, 2021, a US investor subscribed to the acquisition of 3,333,333 units of the Company’s Brain Armor Inc subsidiary, with each unit being comprised of one share of Brain Armor stock, $0.001 par value and a common stock purchase warrant evidencing the right to purchase one share of Common Stock at a per unit price of USD $0.30 for an aggregate purchase price of USD $1,000,000 of which $100,000 was received by the Company on May 13, 2021 and $100,000 on May 27, 2021. This subscription agreement has since been terminated by mutual agreement of Brain Armor Inc. and the investor. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The vesting and exercise prices of the warrants are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">●</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1/3 of shares shall be exercisable 6 months after the subscription date at an exercise price of $0.45 per share</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">● </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1/3 of shares shall be exercisable 12 months after the subscription date at an exercise price of $0.60 per share</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">● </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1/3 of shares shall be exercisable 18 months after the subscription date at an exercise price of $0.75 per share</p></td></tr></tbody></table> 333333 0.001 333333 0.30 100000 0.45 0.60 0.75 3333333 0.001 0.30 1000000 100000 100000 0.45 0.60 0.75 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 8. COMMITMENTS AND CONTINGENCIES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Everlast License Agreement</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 23, 2013, the Company entered into a Deed of Assignment Agreement with Everlast World’s Boxing Headquarters Corporation, International Brand Management Limited, Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast, International Brand, Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition, a New York corporation, has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement, Sports Nutrition Products Incorporated, a wholly owned subsidiary of Trident Brands Incorporated, assigned all of its rights, title, interest and benefit to the trade mark license to the Company effective December 23, 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary, Sports Nutrition Products Inc.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Everlast License Agreement includes a clause stating that Manchester Capital Incorporated will guarantee that the Licensee shall perform all of its obligations and duties under the License Agreement. If the Licensee defaults in the payment when due of any amount it is obliged to pay to Licensor under the License Agreement, or arising from its termination, Manchester Capital is unconditionally responsible to pay that amount to Licensor in the manner prescribed in the License Agreement as if it were the Licensee.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Royalty Calculation, as per the terms of the agreement, are as follows: In 2013, 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014, 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015, 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards, 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed Royalty is $120,000 in 2014, $235,000 in 2015, $320,000 in 2016, $345,000 in 2017 and in 2018 onwards, if the Agreement remains in force, will be 75% of the previous Year’s Royalty Calculation or the previous Year’s Annual Minimum Guaranteed Royalty plus 10%, whichever is greater. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The agreement was terminated on December 31, 2017. On January 17, 2019, Everlast World’s Boxing Headquarters Corp. (“Everlast”) filed a counter claim against the Company and other defendants. In that lawsuit, Everlast seeks payment from the defendants under a License Agreement dated June 4, 2013, for $425,555 in unpaid royalties allegedly due and owing under the License Agreement and interest on the allegedly unpaid royalties of $96,265, which interest allegedly continues to accrue. Everlast has also sought all costs, expenses, and legal fees incurred by Everlast in collecting monies that it claims are due under the License Agreement. On February 26, 2020, the court in the Everlast matter issued an Opinion and Order granting a motion to dismiss all of the Company’s claims against Everlast and granting a motion for judgment on the pleadings as to liability against the Company. The Court left open the question of damages to be awarded to Everlast. The Company had requested that the parties participate in settlement discussions before a magistrate judge or, in the alternative, that Everlast engage in limited discovery on these matters. No settlement was reached. On October 15, 2020, the Court in the Everlast case ordered, adjudged and decreed that Plaintiff Everlast have judgment and recover a total of $738,946 from the Company as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">1. $425,000 representing royalty payments due to Everlast;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">2. Interest on royalty payments computed through October 15, 2020, in the sum of $242,920;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">3. Costs and attorneys’ fees in the sum of $71,026</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On November 17, 2021, The Company entered Into a Stipulation (“Stipulation”) of the litigation captioned Everlast World’s Boxing Headquarters Corp. (“Everlast”) , Plaintiff vs. Trident Brands, Inc. and Manchester Capital Inc., Defendants, Waukesha County Court Case No. 21 TJ 90.  Under the terms of the Stipulation, the Company agreed to pay Everlast on or before February 15, 2022, the sum of $650,000 in full satisfaction of the Everlast’s judgment against the Company in the amount of $738,946. Under the Stipulation, except for the first $250,000 of capital raised, the Company is required to pay Everlast 20% of the gross amount of any capital raising transaction, until the full $650,000 is paid, provided however that the full $650,000 was required to have been paid no later than February 15, 2022.   </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company failed to pay Everlast the full $650,000 by February 15, 2022, as a result of which the Company is obligated to pay Everlast the judgment amount of $738,945, plus applicable interest (a total of $750,713 as of August 21, 2021) and attorney’s fees, less any payments made. The estimated liability as of May 31, 2022 due to accrued interest is $908,799 which the Company has fully accrued. The Company is currently in litigation with Everlast regarding Everlast's methods to collect the judgements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Banc of America Leasing and Capital </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On December 1, 2020, Bank of America Leasing and Capital, LLC filed a legal action against the Company in the Superior Court for the State of California, County of San Mateo (Case NO. 20-CIV-05306), alleging breach of contract. The claim arises out of a software services contract between the Company and Oracle Corporation. Bank of America Leasing and Capital, LLC acquired Oracle’s rights under the agreement. The plaintiff claims the Company is liable for damages in the amount of $217,000 plus interests and costs. The Company has not filed an answer to this complaint. On February 22, 2021, the plaintiff requested that the Court enter a default judgment against the Company. The Company intends to engage counsel and defend against this claim.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">PIT Mycell</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On June 3, 2019, the Company filed a lawsuit against PIT Mycell, LLC, William E. Peterson III, New Age Ventures, LLC, Volker Berl, and Mycell Technologies, LLC (“Mycell”) in the Superior Court in Bergen County, New Jersey, Civil Action No. BER-L-004198-19, in which the Company seeks to require the defendants to perform under and allow the enforcement of certain notes made by Mycell and acquired by the Company in September 2017. The notes are past their stated maturity date of December 31, 2016. The Company also alleges that the parties had entered into a written Settlement Agreement Letter of Intent dated March 14, 2019 (the “Settlement”), but that the defendants repudiated it shortly thereafter. The notes had been the subject of an earlier lawsuit in Virginia in state court in Fairfax County between the Company and PIT Mycell, LLC that the Settlement was intended to resolve. The Company seeks to enforce the notes and the Settlement in the New Jersey lawsuit and requests actual damages in an amount to be proven at trial, attorneys’ fees and litigation costs, specific performance requiring certain defendants to enforce obligations under the notes against Mycell, specific performance requiring the defendants to execute a final Settlement Agreement consistent with the Settlement, an order permitting foreclosure on the collateral for the notes, and declaratory relief. On January 24, 2020, the New Jersey court denied Defendant’s Motions to dismiss the case. The parties have engaged in written discovery and exchanged productions of documents. Mycell filed for bankruptcy on November 25, 2020. The bankruptcy is completed and the Company no longer has a claim on the new company that has since emerged from bankruptcy.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Contingencies</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company may be subject to various legal proceedings and claims that arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. There is significant judgment required in both the probability determination and as to whether an exposure can be reasonably estimated. If any legal matter, that may arise, were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s would reflect any potential claim in the consolidated financial statements for that reporting period.</p> 0.07 7% of 60% 0.08 8% of 60% 0.09 9% of 60% 0.10 10% of 60% 120000 235000 320000 345000 and in 2018 onwards, if the Agreement remains in force, will be 75% of the previous Year’s Royalty Calculation or the previous Year’s Annual Minimum Guaranteed Royalty plus 10%, whichever is greater. 425555 96265 738946 425000 242920 71026 250000 0.20 750713 908799 217000 <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 9. SUBSEQUENT EVENTS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 3, 2022, the Board authorized the following executive compensation plan:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">-</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upon the closing of an initial financing (greater than $2,000,000) then the CEO shall be issued 1.5% of the fully diluted common stock and the Chairman shall receive 1.0% of the fully diluted common stock;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">-</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upon the uplisting of the Company to the New York Stock Exchange (NYSE) or the Nasdaq (whether by merger or operations), then the CEO shall be issued 1.5% of the fully diluted common stock and the Chairman shall receive 1.0% of the fully diluted common stock;</p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 30px; text-align:justify;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">-</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Upon the closing of an acquisition, then the CEO shall be issued a bonus equal 3% of the total enterprise value of the deal and the Chairman shall receive 2% of the total enterprise value of the deal, which may at the option of the Company be paid in cash, or stock. If the bonus is paid in stock, then the stock shall be issued at a 20% discount to the market;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The Company's Board of Directors also established the following compensation and bonus plan for its CEO and reserved some bonus stock in anticipation of hiring a COO and CFO:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Revenue* (in millions)</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Adjusted EBITDA*</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price**</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Percent of Shares </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CEO ***</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Percent of Shares </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>COO***</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Percent of Shares </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CFO***</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">N/A</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.05</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">N/A</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.125</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">N/A</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">80,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.50</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">150,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.75</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">18.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">225,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">30.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">450,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.50</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">45.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">675,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.50</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">75.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,312,500</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">* Until the Company achieves the $8 million revenue target, the executive will earn 100% of eligible shares upon attainment of the relevant revenue target.  Commencing with achievement of the $8 million revenue target, the executive will earn 75% of the eligible shares upon attainment of the revenue target and will earn 25% of the eligible shares upon attainment of the Adjusted EBITDA target.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">** Exercise Price shall be the lower of the Exercise Price set forth above or a 20% discount to the 5-day VWAP</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">** Exercise Price shall not be adjusted accordingly for any stock splits, as these Exercise Prices are after giving effect to the split.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">*** Percent of Shares shall be based on the number of fully diluted common shares</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 3, 2022, the Board also authorized the award of 4,000,000 shares to the Company's employees. The shares will be vested immediately and issued all at once.  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 4, 2022, the Company announced that it filed an amendment to its certificate of incorporation to: (1) authorize 29,320,432 shares of Preferred Stock which it will use to satisfy approximately $17.7 Million of principal and accrued interest due under certain convertible notes, representing a conversion rate of $0.60 per share, and (2) change the name of the corporation to SOLNI Group. The amendment authorizing the Preferred Shares was approved by a majority of the Company’s shareholders and was filed with the State of Nevada on March 31, 2022. The amendments are expected to be effective by September 30, 2022.  </p> Upon the closing of an initial financing (greater than $2,000,000) then the CEO shall be issued 1.5% of the fully diluted common stock and the Chairman shall receive 1.0% of the fully diluted common stock <table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total Revenue* (in millions)</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Adjusted EBITDA*</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Exercise Price**</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Percent of Shares </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CEO ***</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Percent of Shares </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>COO***</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Percent of Shares </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CFO***</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:15%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">N/A</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.05</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:13%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:14%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">N/A</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.125</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">4.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">N/A</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">8.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">80,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.50</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">12.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">150,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.75</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">18.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">225,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">30.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">450,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.50</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">45.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">675,000</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">2.50</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">75.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1,312,500</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5.00</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.00</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">0.25</p></td><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td></tr></tbody></table> 10000.00 0.05 0.0100 0.0025 0.0025 20000.00 0.125 0.0100 0.0025 0.0025 40000.00 0.25 0.0100 0.0025 0.0025 80000.00 80000 0.50 0.0100 0.0025 0.0025 120000.00 150000 0.75 0.0100 0.0025 0.0025 180000.00 225000 1.00 0.0100 0.0025 0.0025 300000.00 450000 1.50 0.0100 0.0025 0.0025 450000.00 675000 2.50 0.0100 0.0025 0.0025 750000.00 1312500 5.00 0.0100 0.0025 0.0025 4000000 29320432 17700000 0.60 EXCEL 40 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 41 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 42 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 147 179 1 false 55 0 false 5 false false R1.htm 000001 - Document - Cover Sheet http://trident.com/role/Cover Cover Cover 1 false false R2.htm 000002 - Statement - Consolidated Balance Sheets Sheet http://trident.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://trident.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 000004 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Sheet http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) Statements 5 false false R6.htm 000006 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://trident.com/role/OrganizationAndDescriptionOfBusiness ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 7 false false R8.htm 000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://trident.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 000009 - Disclosure - GOING CONCERN Sheet http://trident.com/role/GoingConcern GOING CONCERN Notes 9 false false R10.htm 000010 - Disclosure - WARRANTS AND OPTIONS Sheet http://trident.com/role/WarrantsAndOptions WARRANTS AND OPTIONS Notes 10 false false R11.htm 000011 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://trident.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 11 false false R12.htm 000012 - Disclosure - CONVERTIBLE DEBT Sheet http://trident.com/role/ConvertibleDebt CONVERTIBLE DEBT Notes 12 false false R13.htm 000013 - Disclosure - NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC Sheet http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorInc NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC Notes 13 false false R14.htm 000014 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://trident.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 14 false false R15.htm 000015 - Disclosure - SUBSEQUENT EVENTS Sheet http://trident.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 15 false false R16.htm 000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://trident.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 000017 - Disclosure - WARRANTS AND OPTIONS (Tables) Sheet http://trident.com/role/WarrantsAndOptionsTables WARRANTS AND OPTIONS (Tables) Tables http://trident.com/role/WarrantsAndOptions 17 false false R18.htm 000018 - Disclosure - SUBSEQUENT EVENTS (Tables) Sheet http://trident.com/role/SubsequentEventsTables SUBSEQUENT EVENTS (Tables) Tables http://trident.com/role/SubsequentEvents 18 false false R19.htm 000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://trident.com/role/SummaryOfSignificantAccountingPoliciesPolicies 19 false false R20.htm 000020 - Disclosure - GOING CONCERN (Details Narrative) Sheet http://trident.com/role/GoingConcernDetailsNarrative GOING CONCERN (Details Narrative) Details http://trident.com/role/GoingConcern 20 false false R21.htm 000021 - Disclosure - WARRANTS AND OPTIONS (Details) Sheet http://trident.com/role/WarrantsAndOptionsDetails WARRANTS AND OPTIONS (Details) Details http://trident.com/role/WarrantsAndOptionsTables 21 false false R22.htm 000022 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://trident.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://trident.com/role/RelatedPartyTransactions 22 false false R23.htm 000023 - Disclosure - CONVERTIBLE DEBT (Details Narrative) Sheet http://trident.com/role/ConvertibleDebtDetailsNarrative CONVERTIBLE DEBT (Details Narrative) Details http://trident.com/role/ConvertibleDebt 23 false false R24.htm 000024 - Disclosure - NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC (Details Narrative) Sheet http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC (Details Narrative) Details http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorInc 24 false false R25.htm 000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://trident.com/role/CommitmentsAndContingencies 25 false false R26.htm 000026 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://trident.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://trident.com/role/SubsequentEventsTables 26 false false R27.htm 000027 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://trident.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://trident.com/role/SubsequentEventsTables 27 false false All Reports Book All Reports tdnt_10q.htm tdnt-20220531.xsd tdnt-20220531_cal.xml tdnt-20220531_def.xml tdnt-20220531_lab.xml tdnt-20220531_pre.xml tdnt_ex311.htm tdnt_ex312.htm tdnt_ex321.htm tdnt_ex322.htm tdnt_10qimg1.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 46 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tdnt_10q.htm": { "axisCustom": 0, "axisStandard": 17, "contextCount": 147, "dts": { "calculationLink": { "local": [ "tdnt-20220531_cal.xml" ] }, "definitionLink": { "local": [ "tdnt-20220531_def.xml" ] }, "inline": { "local": [ "tdnt_10q.htm" ] }, "labelLink": { "local": [ "tdnt-20220531_lab.xml" ] }, "presentationLink": { "local": [ "tdnt-20220531_pre.xml" ] }, "schema": { "local": [ "tdnt-20220531.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 298, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 7, "http://trident.com/20220531": 4, "http://xbrl.sec.gov/dei/2022": 6, "total": 17 }, "keyCustom": 45, "keyStandard": 134, "memberCustom": 44, "memberStandard": 11, "nsprefix": "tdnt", "nsuri": "http://trident.com/20220531", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://trident.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueOptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000010 - Disclosure - WARRANTS AND OPTIONS", "role": "http://trident.com/role/WarrantsAndOptions", "shortName": "WARRANTS AND OPTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueOptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000011 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://trident.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000012 - Disclosure - CONVERTIBLE DEBT", "role": "http://trident.com/role/ConvertibleDebt", "shortName": "CONVERTIBLE DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "tdnt:NonControllingInterestInvestmentInBrainArmorIncDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000013 - Disclosure - NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC", "role": "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorInc", "shortName": "NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "tdnt:NonControllingInterestInvestmentInBrainArmorIncDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000014 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://trident.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000015 - Disclosure - SUBSEQUENT EVENTS", "role": "http://trident.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://trident.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000017 - Disclosure - WARRANTS AND OPTIONS (Tables)", "role": "http://trident.com/role/WarrantsAndOptionsTables", "shortName": "WARRANTS AND OPTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000018 - Disclosure - SUBSEQUENT EVENTS (Tables)", "role": "http://trident.com/role/SubsequentEventsTables", "shortName": "SUBSEQUENT EVENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31_tdnt_CustomerOneMember_tdnt_RevenueMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31_tdnt_CustomerOneMember_tdnt_RevenueMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000002 - Statement - Consolidated Balance Sheets", "role": "http://trident.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000020 - Disclosure - GOING CONCERN (Details Narrative)", "role": "http://trident.com/role/GoingConcernDetailsNarrative", "shortName": "GOING CONCERN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2021-11-30_tdnt_StockOptionsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000021 - Disclosure - WARRANTS AND OPTIONS (Details)", "role": "http://trident.com/role/WarrantsAndOptionsDetails", "shortName": "WARRANTS AND OPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:FairValueOptionTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2021-11-30_tdnt_StockOptionsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31_tdnt_MrPallanteMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForLoans", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000022 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31_tdnt_MrPallanteMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsForLoans", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "tdnt:ApicReclassifiedToDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000023 - Disclosure - CONVERTIBLE DEBT (Details Narrative)", "role": "http://trident.com/role/ConvertibleDebtDetailsNarrative", "shortName": "CONVERTIBLE DEBT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "tdnt:ApicReclassifiedToDerivativeLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "p", "tdnt:NonControllingInterestInvestmentInBrainArmorIncDisclosureTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2021-05-05_tdnt_BrainArmorIncMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000024 - Disclosure - NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC (Details Narrative)", "role": "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative", "shortName": "NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "tdnt:NonControllingInterestInvestmentInBrainArmorIncDisclosureTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2021-05-05_tdnt_BrainArmorIncMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "tdnt:AccruedInterestLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000025 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "tdnt:AccruedInterestLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2022-03-01to2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000026 - Disclosure - SUBSEQUENT EVENTS (Details)", "role": "http://trident.com/role/SubsequentEventsDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "us-gaap:ScheduleOfSubsequentEventsTextBlock", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31_tdnt_ExercisePriceRangeFiveMember", "decimals": "INF", "lang": null, "name": "tdnt:PercentOfSharesCeo", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-04-04", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000027 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "role": "http://trident.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-04-04", "decimals": "-5", "lang": null, "name": "tdnt:PrincipalAndAccruedInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://trident.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2022-03-01to2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000004 - Statement - Consolidated Statements of Operations (Unaudited)", "role": "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited", "shortName": "Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2022-03-01to2022-05-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2020-11-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000005 - Statement - Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)", "role": "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited", "shortName": "Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "strong", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "AsOf2020-11-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "000006 - Statement - Consolidated Statements of Cash Flows (Unaudited)", "role": "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfCommonStock", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000007 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS", "role": "http://trident.com/role/OrganizationAndDescriptionOfBusiness", "shortName": "ORGANIZATION AND DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://trident.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "000009 - Disclosure - GOING CONCERN", "role": "http://trident.com/role/GoingConcern", "shortName": "GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "tdnt_10q.htm", "contextRef": "From2021-12-01to2022-05-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 55, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line 2" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r385" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r384" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r374" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://trident.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "label": "President And CEO [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r66", "r145", "r150", "r156", "r250", "r251", "r255", "r256", "r294", "r373" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r66", "r145", "r150", "r156", "r250", "r251", "r255", "r256", "r294", "r373" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r111" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r110", "r205", "r206", "r361" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r110", "r205", "r206", "r361" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SubsidiariesMember": { "auth_ref": [ "r208", "r288", "r289", "r291" ], "lang": { "en-us": { "role": { "label": "Brain Armor Inc [Member]" } } }, "localname": "SubsidiariesMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r111", "r290" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative", "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative", "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_AccruedInterestLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued interest liability" } } }, "localname": "AccruedInterestLiability", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_AdditionalFundingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additional funding amount" } } }, "localname": "AdditionalFundingAmount", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_AdjustedEbitda": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Adjusted EBITDA" } } }, "localname": "AdjustedEbitda", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "tdnt_ApicReclassifiedToDerivativeLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "APIC reclassified to derivative liability" } } }, "localname": "ApicReclassifiedToDerivativeLiabilities", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_April132019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "April 13, 2019 [Member," } } }, "localname": "April132019Member", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_AssetAcquisitionsPriceOfAcquisitionExpected": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchase price" } } }, "localname": "AssetAcquisitionsPriceOfAcquisitionExpected", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_AuthorizedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Authorized shares to employees" } } }, "localname": "AuthorizedShares", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "tdnt_BlackScholesModelConversionOption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Black scholes model conversion option" } } }, "localname": "BlackScholesModelConversionOption", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_BlackScholesModelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Black-Scholes Model [Member]" } } }, "localname": "BlackScholesModelMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_BrainArmorIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[Brain Armor Inc [Member]]", "verboseLabel": "Brain Armor Inc [Member]" } } }, "localname": "BrainArmorIncMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_BusinessAcquisitionParValue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Par value" } } }, "localname": "BusinessAcquisitionParValue", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "perShareItemType" }, "tdnt_BusinessAcquisitionShareAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of shares acquired" } } }, "localname": "BusinessAcquisitionShareAcquired", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "sharesItemType" }, "tdnt_CapitalRaised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Capital raised, amount" } } }, "localname": "CapitalRaised", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_CashPaidForAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash paid for:" } } }, "localname": "CashPaidForAbstract", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "tdnt_CommonStockSharesPurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock shares purchased" } } }, "localname": "CommonStockSharesPurchased", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "sharesItemType" }, "tdnt_ContractualLifeInYearsBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding, Contractual Life in Years | Beginning Balance" } } }, "localname": "ContractualLifeInYearsBeginningBalance", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "durationItemType" }, "tdnt_ContractualLifeInYearsEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding, Contractual Life in Years | Ending Balance" } } }, "localname": "ContractualLifeInYearsEndingBalance", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "durationItemType" }, "tdnt_ConversionOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Conversion Option [Member]" } } }, "localname": "ConversionOptionMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_ConvertibleNoteDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible note description" } } }, "localname": "ConvertibleNoteDescription", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "tdnt_Costfordamages": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cost for damages" } } }, "localname": "Costfordamages", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_DecemberOneTwentyTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December 1, 2020 [Member]" } } }, "localname": "DecemberOneTwentyTwentyMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_DescriptionOfPercentageOfRoyaltyCalculation": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of annual minimum guaranteed royalty" } } }, "localname": "DescriptionOfPercentageOfRoyaltyCalculation", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "tdnt_DiscountRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discount rate" } } }, "localname": "DiscountRate", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "tdnt_EarningPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss per share - Basic and diluted" } } }, "localname": "EarningPerShareBasicAndDiluted", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "perShareItemType" }, "tdnt_ExercisPriceRangeEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercis Price Range Eight [Member]" } } }, "localname": "ExercisPriceRangeEightMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "tdnt_ExercisPriceRangeNineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercises Price Range Nine [Member]" } } }, "localname": "ExercisPriceRangeNineMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "tdnt_ExercisableContractualLifeInYearsBeginningBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercisable, Contractual Life in Years | Beginning Balance" } } }, "localname": "ExercisableContractualLifeInYearsBeginningBalance", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "durationItemType" }, "tdnt_ExercisableContractualLifeInYearsEndingBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercisable, Contractual Life in Years | Ending Balance" } } }, "localname": "ExercisableContractualLifeInYearsEndingBalance", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "durationItemType" }, "tdnt_ExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price" } } }, "localname": "ExercisePrice", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "tdnt_ExercisePriceRangeFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Five [Member]" } } }, "localname": "ExercisePriceRangeFiveMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "tdnt_ExercisePriceRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range One [Member]" } } }, "localname": "ExercisePriceRangeOneMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "tdnt_ExercisePriceRangeSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Seven [Member]" } } }, "localname": "ExercisePriceRangeSevenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "tdnt_ExercisePriceRangeSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Six [Member]" } } }, "localname": "ExercisePriceRangeSixMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "tdnt_ExercisePriceRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Two [Member]" } } }, "localname": "ExercisePriceRangeTwoMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "tdnt_ExercisePricesRangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price Range Four [Member]" } } }, "localname": "ExercisePricesRangeFourMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "tdnt_ExercisePricesRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Prices Range Three [Member]" } } }, "localname": "ExercisePricesRangeThreeMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "tdnt_FebruaryFiveTwentyFifteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "February 5, 2015 [Member]" } } }, "localname": "FebruaryFiveTwentyFifteenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_FinalObligationToPayAfterDefaultAsOfAug212021": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Final obligation to pay after default as of Aug, 21, 2021" } } }, "localname": "FinalObligationToPayAfterDefaultAsOfAug212021", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_FirstTrancheMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First Tranche [Member]" } } }, "localname": "FirstTrancheMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_IncreasedTrancheAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Increased tranche amount" } } }, "localname": "IncreasedTrancheAmount", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_InterestAmortized": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest amortized" } } }, "localname": "InterestAmortized", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_IntrinsicValueOfNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Intrinsic value of notes" } } }, "localname": "IntrinsicValueOfNotes", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_InventoryNetOfReserves": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, net of reserves" } } }, "localname": "InventoryNetOfReserves", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "tdnt_JuneFourTwentyThirteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "June 4, 2013 [Member]" } } }, "localname": "JuneFourTwentyThirteenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_MayFourteenTwentyFifteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 14, 2015 [Member]" } } }, "localname": "MayFourteenTwentyFifteenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_MayNineTwentySeventeenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 9, 2017 [Member]" } } }, "localname": "MayNineTwentySeventeenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_MaySixteenTwentyEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "May 16, 2018 [Member]" } } }, "localname": "MaySixteenTwentyEighteenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_MrPallanteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mr. Pallante [Member]" } } }, "localname": "MrPallanteMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_NciInvestmentInBrainArmor": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "NCI Investment in Brain Armor" } } }, "localname": "NciInvestmentInBrainArmor", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "tdnt_NonControllingInterestInvestmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC" } } }, "localname": "NonControllingInterestInvestmentAbstract", "nsuri": "http://trident.com/20220531", "xbrltype": "stringItemType" }, "tdnt_NonControllingInterestInvestmentInBrainArmorIncDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NON-CONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR, INC." } } }, "localname": "NonControllingInterestInvestmentInBrainArmorIncDisclosureTextBlock", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorInc" ], "xbrltype": "textBlockItemType" }, "tdnt_November302018Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "November 30, 2018 [Member]" } } }, "localname": "November302018Member", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_NovemberSixTwentyNinteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "November 6, 2019 [Member]" } } }, "localname": "NovemberSixTwentyNinteenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_NumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of customers" } } }, "localname": "NumberOfCustomers", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "integerItemType" }, "tdnt_PaymentOfUnpaidInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Payment of unpaid interest" } } }, "localname": "PaymentOfUnpaidInterest", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_PaymentOfUnpaidRoyalties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Payment of unpaid royalties" } } }, "localname": "PaymentOfUnpaidRoyalties", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_Paymentdue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Payment due" } } }, "localname": "Paymentdue", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_PercentOfSharesCeo": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percent of Shares CEO" } } }, "localname": "PercentOfSharesCeo", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "tdnt_PercentOfSharesCfo": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percent of Shares CFO" } } }, "localname": "PercentOfSharesCfo", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "tdnt_PercentOfSharesCoo": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percent of Shares COO" } } }, "localname": "PercentOfSharesCoo", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "tdnt_PercentageOfDirectResponseSalesRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage of direct response sales revenue" } } }, "localname": "PercentageOfDirectResponseSalesRevenue", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "tdnt_PercentageOfGrossAmountToPayForCapitalRaisingTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage of gross amount to pay for capital raising transaction, until the full amount paid" } } }, "localname": "PercentageOfGrossAmountToPayForCapitalRaisingTransaction", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "tdnt_PercentageOfNetRetailSales": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Percentage of net retail sales" } } }, "localname": "PercentageOfNetRetailSales", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "tdnt_PlantiffEverlastMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Plantiff Everlast[Member]" } } }, "localname": "PlantiffEverlastMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_PrincipalAndAccruedInterest": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Principal and accrued interest" } } }, "localname": "PrincipalAndAccruedInterest", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_ProceedsFromNciInvestmentInBrainArmor": { "auth_ref": [], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Proceeds from NCI Investment in Brain Armor" } } }, "localname": "ProceedsFromNciInvestmentInBrainArmor", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "tdnt_RangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range One [Member]" } } }, "localname": "RangeOneMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_RangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range Three [Member]" } } }, "localname": "RangeThreeMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_RangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range Two [Member]" } } }, "localname": "RangeTwoMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_Recoveryamount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Recovery, amount" } } }, "localname": "Recoveryamount", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "tdnt_RevalueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Re-value [Member]" } } }, "localname": "RevalueMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_RevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue [Member]" } } }, "localname": "RevenueMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_RoyaltyCalculationYear2013Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Royalty Calculation Year 2013 [Member]" } } }, "localname": "RoyaltyCalculationYear2013Member", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_RoyaltyCalculationYear2014Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Royalty Calculation Year 2014 [Member]" } } }, "localname": "RoyaltyCalculationYear2014Member", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_RoyaltyCalculationYearFifteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Royalty Calculation Year 2015 [Member]" } } }, "localname": "RoyaltyCalculationYearFifteenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_RoyaltyCalculationYearTwoThousandSixteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Royalty Calculation Year 2016 [Member]" } } }, "localname": "RoyaltyCalculationYearTwoThousandSixteenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_SecondTrancheMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Second Tranche [Member]" } } }, "localname": "SecondTrancheMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_SeptemberTwoSixTwentySixteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "September 26, 2016 [Member]" } } }, "localname": "SeptemberTwoSixTwentySixteenMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Stock Options [Member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "domainItemType" }, "tdnt_SubscriptionArrangementOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercisable after 12 months [Member]" } } }, "localname": "SubscriptionArrangementOneMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_SubscriptionArrangementTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercisable after 18 months [Member]" } } }, "localname": "SubscriptionArrangementTwoMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_ThirdTrancheMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Tranche [Member]" } } }, "localname": "ThirdTrancheMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_TwentySixteenNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2016 Notes [Member]" } } }, "localname": "TwentySixteenNotesMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_TwoThousandEighteenConvertibleNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2018 Convertible Note [Member]" } } }, "localname": "TwoThousandEighteenConvertibleNoteMember", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "tdnt_Volatility": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the s", "label": "Volatility" } } }, "localname": "Volatility", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "tdnt_VolatilityRate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Volatility rate" } } }, "localname": "VolatilityRate", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "tdnt_WeightedAverageNumbersOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of common shares outstanding - Basic and diluted" } } }, "localname": "WeightedAverageNumbersOfShareOutstandingBasicAndDiluted", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "sharesItemType" }, "tdnt_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://trident.com/20220531", "presentation": [ "http://trident.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r21", "r297" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r112", "r113" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, net of allowance for doubtful accounts of $11,286 and $160,210, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForEnvironmentalLossContingenciesDiscountRate": { "auth_ref": [ "r137", "r142" ], "lang": { "en-us": { "role": { "documentation": "Rate applied to the undiscounted amount of environmental loss contingencies to arrive at the present value recorded as of the balance sheet date.", "label": "[Accrual for Environmental Loss Contingencies, Discount Rate]", "verboseLabel": "Discount rate" } } }, "localname": "AccrualForEnvironmentalLossContingenciesDiscountRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r13", "r297" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r68", "r69", "r70", "r241", "r242", "r243", "r262" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r55", "r136" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortized for prior year" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r18", "r114", "r123", "r125", "r127" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowances for account receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r44", "r55", "r178", "r280" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r39", "r55", "r178", "r282" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of debt" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r8", "r64", "r97", "r100", "r106", "r121", "r145", "r146", "r147", "r149", "r150", "r151", "r152", "r153", "r154", "r156", "r157", "r250", "r255", "r269", "r295", "r297", "r345", "r355" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets]", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r20", "r64", "r121", "r145", "r146", "r147", "r149", "r150", "r151", "r152", "r153", "r154", "r156", "r157", "r250", "r255", "r269", "r295", "r297" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "[Assets, Current]", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r210", "r211", "r212", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r230", "r231", "r233", "r234", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Information by date or year award under share-based payment arrangement is granted.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r210", "r211", "r212", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r230", "r231", "r233", "r234", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Per unit price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NONCONTROLLING INTEREST INVESTMENT IN BRAIN ARMOR INC (Details Narrative)" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r7", "r297", "r368", "r369" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "[Cash]", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/GoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r7", "r57" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF PERIOD", "periodStartLabel": "CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets", "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r50", "r272" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "[Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect]", "totalLabel": "NET CHANGE IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CededCreditRiskAxis": { "auth_ref": [ "r352", "r367" ], "lang": { "en-us": { "role": { "documentation": "Information by name of reinsurer or group of reinsurers in reinsurance contract.", "label": "Reinsurer, Name [Axis]" } } }, "localname": "CededCreditRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CededCreditRiskReinsurerDomain": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Name of reinsurer or group of reinsurers in reinsurance contract." } } }, "localname": "CededCreditRiskReinsurerDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ChangeInAccountingEstimateByTypeAxis": { "auth_ref": [ "r76", "r82" ], "lang": { "en-us": { "role": { "documentation": "Information by type of change in accounting estimate.", "label": "Change in Accounting Estimate by Type [Axis]" } } }, "localname": "ChangeInAccountingEstimateByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInAccountingEstimateTypeDomain": { "auth_ref": [ "r76", "r82" ], "lang": { "en-us": { "role": { "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities." } } }, "localname": "ChangeInAccountingEstimateTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r196", "r209" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "One third warrant exercise price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r138", "r139", "r140", "r143", "r372" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "verboseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r68", "r69", "r262" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, shares par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r11", "r192" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r11", "r297" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value, 300,000,000 shares authorized; 37,311,887 and 33,311,887 shares issued and outstanding as of May 31, 2022 and November 30, 2021 respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r88", "r89", "r110", "r267", "r268", "r371" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r88", "r89", "r110", "r267", "r268", "r367", "r371" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r88", "r89", "r110", "r267", "r268" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r158", "r159", "r160", "r162", "r170", "r171", "r172", "r174", "r175", "r176", "r177", "r178", "r185", "r186", "r187", "r188" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtNoncurrent": { "auth_ref": [ "r28" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.", "label": "Convertible Debt, net of discount of $0 and $0, respectively" } } }, "localname": "ConvertibleDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r9", "r346", "r356", "r370" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible promissory notes" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r41", "r64", "r121", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r154", "r156", "r157", "r269" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Sales" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r59", "r60" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Common stock conversion, shares" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONVERTIBLE DEBT" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r63", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r173", "r179", "r180", "r182", "r189" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "CONVERTIBLE DEBT" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r9", "r183", "r346", "r354" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Aggregate amount of promissory note" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "auth_ref": [ "r194" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.", "label": "Beneficial conversion feature" } } }, "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r161", "r184" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Conversion price (in dollars per share)", "verboseLabel": "Conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative", "http://trident.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r159", "r185", "r186", "r281", "r283", "r284" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principal amount of debt" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r26", "r175", "r281" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt instrument interest rate" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r26", "r160" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Bearing interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r27", "r162", "r264" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Extended maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r170", "r280", "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent": { "auth_ref": [ "r280", "r284" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.", "label": "Debt discount, convertible debt non-current" } } }, "localname": "DebtInstrumentUnamortizedDiscountNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueArrangementTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of deferred revenue arrangement.", "label": "Deferred Revenue Arrangement Type [Axis]" } } }, "localname": "DeferredRevenueArrangementTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredRevenueArrangementTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of obligation arising when an entity receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized." } } }, "localname": "DeferredRevenueArrangementTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DueFromRelatedParties": { "auth_ref": [ "r12", "r65", "r148", "r150", "r151", "r155", "r156", "r157", "r289", "r348", "r359" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.", "label": "Due to related party" } } }, "localname": "DueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": { "auth_ref": [ "r260" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.", "label": "Embedded conversion" } } }, "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r32", "r33", "r34", "r68", "r69", "r70", "r72", "r77", "r79", "r83", "r122", "r192", "r195", "r241", "r242", "r243", "r246", "r247", "r262", "r273", "r274", "r275", "r276", "r277", "r278", "r285", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_ExtinguishmentOfDebtAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of debt extinguished.", "label": "Debt extinguisment" } } }, "localname": "ExtinguishmentOfDebtAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r265", "r266" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOptionTextBlock": { "auth_ref": [ "r270", "r271" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide. Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.", "label": "Fair Value, Option [Text Block]", "verboseLabel": "WARRANTS AND OPTIONS" } } }, "localname": "FairValueOptionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptions" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r116", "r117", "r118", "r119", "r120", "r124", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r181", "r191", "r261", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r377", "r378", "r379", "r380", "r381", "r382", "r383" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r141" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Litigation settlement, amount" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r43" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "[General and Administrative Expense]", "negatedLabel": "General & Administrative Expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r40", "r64", "r97", "r99", "r102", "r105", "r107", "r121", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r154", "r156", "r157", "r269" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "[Gross Profit]", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossAttributableToParent": { "auth_ref": [ "r34", "r42" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.", "label": "Net loss attributable to Trident" } } }, "localname": "IncomeLossAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Operations (Unaudited)" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r54" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r54" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r54" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r54" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r35", "r96", "r279", "r282", "r350" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited": { "order": 6.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "[Interest Expense]", "negatedLabel": "Interest Expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest payment" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r48", "r51", "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r19", "r297" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, net of reserves of $401,606 and $401,606, respectively" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r23", "r64", "r101", "r121", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r154", "r156", "r157", "r251", "r255", "r256", "r269", "r295", "r296" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "[Liabilities]", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r17", "r64", "r121", "r269", "r297", "r347", "r358" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "[Liabilities and Equity]", "totalLabel": "TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES & STOCKHOLDERS' DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r25", "r64", "r121", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r154", "r156", "r157", "r251", "r255", "r256", "r269", "r295", "r296", "r297" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "[Liabilities, Current]", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicenseAgreementTermsMember": { "auth_ref": [ "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Terms of the license agreements under research and development arrangements accounted for as a contract to perform research and development for others.", "label": "License Agreement [Member]" } } }, "localname": "LicenseAgreementTermsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WARRANTS AND OPTIONS (Tables)" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LitigationSettlementExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.", "label": "Cost and attorney's fees" } } }, "localname": "LitigationSettlementExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r9", "r346", "r353" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Total loan" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r28", "r144" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r50" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "[Net Cash Provided by (Used in) Financing Activities]", "totalLabel": "Cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r50", "r53", "r56" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "[Net Cash Provided by (Used in) Operating Activities]", "totalLabel": "Cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r30", "r31", "r34", "r37", "r56", "r64", "r71", "r73", "r74", "r75", "r76", "r78", "r79", "r81", "r97", "r99", "r102", "r105", "r107", "r121", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r154", "r156", "r157", "r263", "r269", "r349", "r360" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "[Net Income (Loss) Attributable to Parent]", "totalLabel": "Net Loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited", "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r30", "r31", "r34", "r78", "r79", "r253", "r257" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net loss attributable to Non-Controlling Interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncontrollingInterestInVariableInterestEntity": { "auth_ref": [], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Portion of equity (net assets) in a variable interest entity (VIE) not attributable, directly or indirectly, to the parent entity. That is, this is the portion of equity in a VIE that is attributable to the noncontrolling interest (previously referred to as minority interest).", "label": "Non-Controlling Interest in Subsidiary" } } }, "localname": "NoncontrollingInterestInVariableInterestEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r68", "r69", "r70", "r195", "r248" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Non- Controlling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income (Expenses)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r97", "r99", "r102", "r105", "r107" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "[Operating Income (Loss)]", "totalLabel": "Loss from Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ORGANIZATION AND DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r67", "r80", "r93", "r259" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "verboseLabel": "ORGANIZATION AND DESCRIPTION OF BUSINESS" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/OrganizationAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r45" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "[Other Nonoperating Income (Expense)]", "totalLabel": "Total Other Income (Expenses)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "WARRANTS AND OPTIONS" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForLoans": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments for and related to principal collection on loans related to operating activities.", "label": "Additional payment of loan" } } }, "localname": "PaymentsForLoans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRoyalties": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid for royalties during the current period.", "label": "Ineterest royalty payment" } } }, "localname": "PaymentsForRoyalties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r210", "r211", "r212", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r230", "r231", "r233", "r234", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative", "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative", "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r210", "r211", "r212", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r230", "r231", "r233", "r234", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative", "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative", "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r10", "r190" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares", "verboseLabel": "Preferred stock, shares" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative", "http://trident.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r10", "r297" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock shares, amount" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r20" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r47" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from convertible debt" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r46" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "[Proceeds from Issuance of Common Stock]", "verboseLabel": "Issuance of Common Shares for services, amount" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r47" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from promissory note" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r30", "r31", "r34", "r49", "r64", "r71", "r78", "r79", "r97", "r99", "r102", "r105", "r107", "r121", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r154", "r156", "r157", "r249", "r252", "r254", "r257", "r258", "r263", "r269", "r351" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r38", "r126" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for bad debts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r208", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r208", "r288", "r291", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r286", "r287", "r289", "r292", "r293" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "verboseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": { "auth_ref": [ "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Information by form of arrangement related to research and development.", "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": { "auth_ref": [ "r244", "r245" ], "lang": { "en-us": { "role": { "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others." } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r14", "r195", "r297", "r357", "r365", "r366" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r68", "r69", "r70", "r72", "r77", "r79", "r122", "r241", "r242", "r243", "r246", "r247", "r262", "r362", "r364" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r62", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r207" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Customer Concentration" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r36", "r64", "r94", "r95", "r98", "r103", "r104", "r108", "r109", "r110", "r121", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r154", "r156", "r157", "r269", "r351" ], "calculation": { "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited": { "order": 3.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues, net", "verboseLabel": "Total Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfOperationsUnaudited", "http://trident.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GOING CONCERN" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RoyaltyGuaranteesCommitmentsAmount": { "auth_ref": [ "r332" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount the entity has committed to make for future royalty guarantees.", "label": "Annual Minimum Guaranteed Royalty" } } }, "localname": "RoyaltyGuaranteesCommitmentsAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r213", "r229", "r232" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsequentEventsTextBlock": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.", "label": "Schedule of subsequent events" } } }, "localname": "ScheduleOfSubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SubsequentEventsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price]", "periodEndLabel": "Weighted Average Exercise Price, Exercisable | Ending Balance", "periodStartLabel": "Weighted Average Exercise Price, Exercisable | Begnning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Options, Forfeited or Expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Options, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r214", "r215" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number]", "periodEndLabel": "Options, Outstanding | Ending Balance", "periodStartLabel": "Options, Outstanding | Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r214", "r215" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, Ending Balance", "periodStartLabel": "Weighted Average Exercise Price, Outstanding, Begnning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "[Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable]", "periodStartLabel": "Options, Exercisable | Beginning Balance" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r235" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r240" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value]", "periodEndLabel": "Exercisable Intrinsic Value | Ending Balance", "periodStartLabel": "Exercisable Intrinsic Value | Beginning Balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "[Shares, Issued]", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r61", "r67" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r29", "r32", "r33", "r34", "r68", "r69", "r70", "r72", "r77", "r79", "r83", "r122", "r192", "r195", "r241", "r242", "r243", "r246", "r247", "r262", "r273", "r274", "r275", "r276", "r277", "r278", "r285", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited", "http://trident.com/role/ConvertibleDebtDetailsNarrative", "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative", "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative", "http://trident.com/role/SubsequentEventsDetails", "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Cash Flows (Unaudited)" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r68", "r69", "r70", "r83", "r331" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited", "http://trident.com/role/ConvertibleDebtDetailsNarrative", "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative", "http://trident.com/role/RelatedPartyTransactionsDetailsNarrative", "http://trident.com/role/SubsequentEventsDetails", "http://trident.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Issuance of Common Shares for services, share" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r10", "r11", "r192", "r195", "r219" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Options, Exercised or Vested" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/WarrantsAndOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Issuance of Common Shares for services, amount" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r11", "r15", "r16", "r64", "r115", "r121", "r269", "r297" ], "calculation": { "http://trident.com/role/ConsolidatedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "[Stockholders' Equity Attributable to Parent]", "periodEndLabel": "Balance, amount", "periodStartLabel": "Balance, amount", "totalLabel": "Total Stockholders' Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets", "http://trident.com/role/ConsolidatedStatementsOfChangesInStockholdersDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubscriptionArrangementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of deferred revenue by arrangement wherein a subscribers pay in advance for media (TV, newspaper, magazine, internet), which will generally be recognized as revenue as the media is delivered.", "label": "Subscription Arrangement [Member]" } } }, "localname": "SubscriptionArrangementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/NoncontrollingInterestInvestmentInBrainArmorIncDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventDescription": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.", "label": "Subsequent description" } } }, "localname": "SubsequentEventDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r298", "r300" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "verboseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Substantial Doubt about Going Concern [Text Block]", "verboseLabel": "GOING CONCERN" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/GoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r116", "r117", "r118", "r119", "r120", "r181", "r191", "r261", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r377", "r378", "r379", "r380", "r381", "r382", "r383" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r84", "r85", "r86", "r87", "r90", "r91", "r92" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates and Assumptions" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r210", "r211", "r212", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r230", "r231", "r233", "r234", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r210", "r211", "r212", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r230", "r231", "r233", "r234", "r235", "r236", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://trident.com/role/ConvertibleDebtDetailsNarrative" ], "xbrltype": "domainItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q1)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r143": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r189": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r259": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14217-108612" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "825", "URI": "https://asc.fasb.org/topic&trid=2134543" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r300": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473578&loc=d3e63223-108013" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.10(3))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.3)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r374": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r375": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r376": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r377": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r378": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r379": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r380": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r381": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r382": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r383": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r384": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r385": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.20)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r67": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e777-108305" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" } }, "version": "2.1" } ZIP 47 0001477932-22-005413-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-22-005413-xbrl.zip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